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TLR-independent activation of NK cells during systemic inflammation.
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Introduction: During the course of systemic inflammation, most of the
immune cell types get activated to a certain degree as part of, or
contributing to, the cascade of physiopathological events. Whether for some
cells, classically phagocytes of the innate immune system, it is clear that
direct sensing of pathogen-associated molecular patterns leads to activation
initiating systemic inflammation, the picture is not so clear for natural killer
(NK) cells. While NK cells have been shown to express toll-like receptors
(TLR), the role of these receptors on NKs during systemic inflammation has
not been directly addressed.
Methods: To directly assess the role of TLR expression on NK cells we
used an adoptive transfer model in which NKs purified from the spleens
of WT, TLR4KO and TLR2/4DKO mice were transferred intravenously to
RAG2-/-gc-/- (devoid of T, B and NK cells). Five days after reconstitution the
mice were challenged intraperitoneally with conventional or TLR-grade
lipopolysaccharide (LPS). Immune cell activation and production of IFNg
by NK cells was determined after 6 hours by FACS analysis.
Results: We observed no differences in reconstitution of the recipient
mice with NK cells from different backgrounds suggesting no difference
in trafficking and survival of the transferred cells. At 6 hours after LPS
challenge, WT, TLR4KO or TLR2/4DKO NK cells recovered from the spleen
and lungs of RAG2-/-gc-/- mice showed comparable levels of CD69
activation marker expression. Intracellular labeling for IFNg in NK cells also
revealed no significant differences.
Conclusion: Whether there is a role for direct TLR signaling on NK cells
remains the objective of further investigations; however, our data show
that in the course of a systemic inflammatory process, like endotoxinemia,
the expression of TLR2 and TLR4 by NK cells makes no difference in terms
of their activation and secretion of IFNg
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Introduction: Lactate is one of biomarkers used for risk stratification,
resuscitation target, and death prediction in sepsis [1,2]. Interpretation of
lactate clearance was proven more superior than single measurement to
evaluate resuscitation adequacy and to determine prognosis [3,4]. This study
aimed to find out whether mean differences of 6-hour, 12-hour, and 24-hour
lactate clearance were observed between nonsurvivors and survivors of
acute phase mortality in severe sepsis and septic shock patients.
Methods: The study design was prospective cohort. Subjects were
collected by consecutive sampling from the emergency department,
hospital ward, and ICU at Cipto Mangunkusumo Hospital, Jakarta. Lactate
levels were measured at 6, 12, and 24 hours, and subjects were
subsequently followed to evaluate 3-day mortality. To determine their
association with mortality, we used mean difference analysis of those
three lactate clearance periods between nonsurvivors and survivors. In
addition, to determine the cutoff value, we used receiver operator curve
analysis.
Results: Eighty-one subjects were included in this study. Eighty of
81 were followed until 12 hours, and 72 out of 80 were followed until
24 hours. Twenty-five subjects (31%) did not survive within 3 days of
hospitalization. Only 24-hour lactate clearance had significant median
difference (-17.0% in nonsurvivor vs. 15.2% in survivor group; P = 0.034).
The best cutoff value for 24-hour lactate clearance was -6.0% (AUC 0.744,
sensitivity 62.5% and specificity 87.5%, positive predictive value 58.8%
and negative predictive value 89.1%, relative risk 5.39). From multivariate
analysis, 24-hour lactate clearance was proven to be an independent
predictor of mortality.
Conclusion: Median of 24-hour lactate clearance was significantly lower
in nonsurvivors of severe sepsis and septic shock patients. Its cutoff value
was -6.0%.
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Introduction: Myeloid-derived suppressor cells (MDSCs) constitute a
heterogeneous population of immature myeloid cells that potently
suppress immune responses. They were originally identified in cancer
patients and have since been reported to occur also in chronic
inflammation, autoimmunity and even bacterial infections. Human MDSCs
are commonly divided into monocytic (Mo-MDSCs) and granulocytic
(PMN-MDSCs) subtypes. To what extent the bona fide cancer MDSCs are
representative of the proposed MDSCs found in other diseases is not well
known. PMN-MDSCs have previously been found to be enriched among
low-density granulocytes (LDGs) in density gradient centrifuged blood.
Methods: In this study we analyzed potential MDSCs in sepsis patients
with different causative microorganisms, using total peripheral blood as
compared to density gradient centrifuged blood.
Results: We found a high frequency of typical CD14+HLADRlow Mo-
MDSCs in all sepsis patients, whereas the typical PMN-MDSCs as well as a
prominent CD14low PMN-MDSC-like population appeared preferentially in
Gram-positive cases (Figures 1 to 3). The CD14low PMN-MDSC variant was
demonstrated to suppress T-cell proliferation in vitro via a ROS-dependent
mechanism, to display an increased IL-10:TNFa ratio, and to present with
signs of immaturity: blast morphology and low cytokine levels (Figures 4
and 5).
Conclusion: We conclude that a spectrum of cells with MDSC features
are enriched in sepsis, and that microbial origin of sepsis contributes to
the substantial interindividual patient variation in MDSC pattern.
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Introduction: Among methods for preventing pneumonia and possibly
also bacteremia in ICU patients, selective digestive decontamination (SDD;
topical with or without protocolized parenteral antibiotic) appears most
effective within randomized concurrent controlled trials (RCCTs) [1].
However, whether parenteral antibiotic is required, and whether SDD
actually increases pneumonia incidences in SDD RCCTs versus the
broader ICU pneumonia evidence base, remain unresolved [2,3]. The
purpose of this analysis is to test for counterfactual and contextual effects
of the topical and parenteral SDD components on the bacteremia
incidence versus the broader evidence base related to the patient group
at risk of VAP.
Methods: Bacteremia incidence proportion data were extracted from
component (control and intervention) groups from studies investigating
antibiotic (SDD) or nonantibiotic methods of VAP prevention. Both the
counterfactual and the contextual effects of SDD factorized as topical or
protocolized parenteral exposures were estimated using random-effects
meta-analysis of study and group level data. Studies without any
prevention methods under study constituted the reference category
(benchmark groups).
Results: As a counterfactual within RCCTs, SDD when given as combined
topical and parenteral antibiotic appears to halve the bacteremia
incidence (odds ratio (OR) 0.59; 0.48 to 0.73; n = 18 studies). As a
contextual however, the mean bacteremia incidence among 27 control
groups (17.1%; 13.1 to 22.1%) and 12 intervention groups receiving
topical antibiotic alone (16.2%; 9.1 to 27.3%) from SDD RCCTs is double
that of 36 benchmark groups (8.3; 7.0 to 10.8%) and 19 control groups
from studies of nonantibiotic methods (7.7%; 5.2 to 11.1). The upward
dispersion in bacteremia incidence among component groups from SDD
RCCTs away from this benchmark is striking with all but two of the 27
control groups and all but two of 12 SDD intervention groups that did
not receive PPAP being above this benchmark.
Conclusion: The major contextual hazard of SDD toward bacteremia
among ICU patients is inapparent within individual studies. The apparent
protection in SDD RCCTs is spurious as the SDD counterfactual is
conflated by the strong contextual effect with partial mitigation by SDD
Figure 1(abstract P3)
Figure 2(abstract P3)
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protocolized parenteral antibiotic. Not only is the safety of SDD within the
ICU environment unclear, but this SDD contextual effect may conflate the
apparent SDD counterfactual effect on the incidence of bacteremia, as
with VAP.
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Introduction: Thalidomide (a-naphthylimidoglutarimide), a psychoactive
drug that readily crosses the blood-brain barrier, has been shown to
exhibit anti-inflammatory, anti-angiogenic, immunomodulatory properties
through a mechanism that is not fully established. Keeping these
properties in mind, we have tried to find out the anti-inflammatory and
immunomodulatory properties of thalidomide in mouse model of acute
inflammation by introducing Klebsiella pneumoniae B5055 in BALB/c mice
via the intranasal route.
Methods: Acute lung infection (ALI) or pneumonia in BALB/c mice was
induced via instillation of selected dose (104 CFU/ml) of bacteria (that is,
K. pneumoniae B5055) intranasally. Mice were observed for 7 days and
lungs were isolated on designated days for studying difference in
bacterial load and other proinflammatory mediators using standard
biochemical methods and ELISA.
Results: The intranasal instillation of bacteria in this mouse model of
acute pneumonia-induced inflammation led to significant increase in
neutrophil infiltration into the lungs. This was further accompanied by an
increased production of proinflammatory cytokines (that is, TNFa and
IL-1a) and other mediators of inflammation (that is, malondialdehyde
(MDA), myeloperoxidase (MPO) and nitric oxide (NO)) in the lung tissue.
The animals, which received thalidomide alone orally or in combination
with augmentin, 30 minutes prior to bacterial instillation into the lungs
via intranasal route, showed significant (P ≤ 0.05) decrease in neutrophil
influx into the lungs. A significant (P ≤ 0.05) decrease in the production
of proinflammatory cytokines (that is, TNFa and IL-1a) and other
biochemical mediators of acute inflammation (that is, MDA, MPO, and
NO) was also observed in this group. But the augmentin treatment alone
did not decrease these proinflammatory mediators significantly (P ≥0.05)
as compared to the control group.
Conclusion: We therefore conclude that thalidomide ameliorates lung
inflammation induced by K. pneumoniae B5055 without significantly (P ≤ 0.05)
decreasing the bacterial load in the lung tissue whereas augmentin takes care
of bacterial proliferation. Hence, it can be used as an adjunct therapy along
with antibiotics as an anti-inflammatory or an immunomodulatory agent in
case of acute lung infection or pneumonia.
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Introduction: Purulent complications in patients with type 2 diabetes are
usually severe, often complicated by sepsis and require emergency
surgery. Noncardiac surgery is associated with a 7 to 11% complication
rate and mortality of 0.8 to 1.5% [1], up to 42% are cardiac reasons [2].
After surgery, 2% of patients suffer major cardiac complications [3], and
8% show evidence of significant myocardial injury [2]. The aim of this
study was to identify the impact of purulent complications and sepsis on
cardiovascular system in patients with type 2 diabetes.
Methods: We analyzed 112 consecutive patients (54 men and 58 women)
aged 57.2 ± 8.4 years with purulent-necrotic complications (gangrene,
phlegmon, and abscess) of type 2 diabetes and sepsis in 2013. We compared
laboratory and instrumental data (blood tests, ECG, echocardiography and
others), which were previously obtained in the same patients receiving
inpatient treatment before sepsis (2011 to 2012).
Results: Gangrene of lower extremities in 59 (52.7%) prevailed among
purulent complications. After the development of sepsis we detected in all
patients significantly increased heart rate, respiratory rate per minute,
leukocytosis, anemia, worse glucose metabolism and renal function (Table 1).
Congestive heart failure became more severe. This was confirmed by
decrease of left ventricle ejection fraction (55.2 ± 5.1% before sepsis vs.
49.3 ± 4.1% after) and increase brain natriuretic peptide (291.4 ± 34.5 ng/ml
vs. 395.2 ± 28.1 ng/ml, P < 0.001). Prior sepsis in 66 (58.9%) of patients with
arterial hypertension was observed, after in 88 (78.6%). After admission to
Table 1(abstract P6) Hemodynamic parameters and blood tests in patients with purulent complications of type 2
diabetes and sepsis
Parameter Before sepsis (n = 112) After sepsis (n = 112) P value
Heart rate (beats/minute) 78.4 ± 15.2 112.5 ± 18.9 < 0.001
Respiratory rate (breaths/minute) 18.0 ± 2.0 29.5 ± 5.5 < 0.001
Systolic BP (mmHg) 155.7 ± 35.4 154.2 ± 58.5 n.s
Diastolic BP (mmHg) 90.4 ± 10.3 91.9 ± 8.6 n.s
Left ventricle ejection fraction (%) 55.2 ± 5.1 49.3 ± 4.1 0.033
Fasting plasma glucose (mmol/l) 8.4 ± 2.5 15.4 ± 4.8 < 0.001
Two-hour plasma glucose (mmol/l) 10.2 ± 2,8 19.9 ± 3.3 < 0.001
HbA1c (%) 8.4 ± 0.5 12.1 ± 0.5 < 0.001
Hemoglobin (g/l) 121.5 ± 12.5 105.4 ± 11.7 0.04
White count (103) 6.7 ± 1.2 14.4 ± 2.1 < 0.001
Fibrinogen (mg%) 411.6 ± 103.6 715.4 ± 215.5 < 0.001
Blood urea (mmol/l) 6.1 ± 2.9 8.8 ± 2.5 0.011
Blood creatinine (mmol/l) 88.4 ± 18.5 105.6 ± 17.3 0.02
Brain natriuretic peptide (ng/ml) 291.4 ± 34.5 395.2 ± 28.1 < 0.001
BP, blood pressure; HbA1c, glycosylated hemoglobin A1c
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the centre, patients had no signs of septic shock. In 13 (11.6%) patients, the
perioperative period was complicated by acute myocardial infarction, which
was accompanied by a fall in blood pressure. We detected an increase of the
functional class of stable angina, congestive heart failure, 4.2 times increased
incidence of unstable angina, 2.6 times ventricular and four times
supraventricular extra systole after septic complications (Table 2).
Conclusion: After the development of purulent complications and sepsis
in patients with type 2 diabetes, we observed increased incidence of
arterial hypertension, arrhythmias, worsened severity of coronary artery
disease and congestive heart failure. Perioperative risk of acute
myocardial infarction amounted to 11.6%.
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Introduction: Lung abscesses and gangrene are the most severe clinical
manifestation and outcome among acute purulent destructive pulmonary
disease (APDPD). Mortality ranges from 10 to 35%, and in the presence of
diabetes increases up to 30 to 90% [1]. The main reason for this is the
generalization of infection (sepsis), leading to the development of multiple
organ failure [2,3]. The aim of this study was to identify the severity of sepsis
in patients with APDPD depending on the presence of type 2 diabetes, and
the impact on the forecast.
Methods: During the period 2012 to 2013, we examined 408 patients aged
48.5 ± 12.5 years (258 men/150 women) who underwent surgical treatment
for APDPD. The patients were divided into two groups: 144 patients with
type 2 diabetes, and controls (n = 246). We carried out computed
tomography, ECG, echocardiography, laboratory biochemical testing, and
bacteriological analysis of pathologic material and blood samples.
Results: Patients with type 2 diabetes had much more complications and
cases of severe sepsis and septic shock (Table 1). Bacteriological analysis
of the pathologic material showed Gram-positive bacteria in 35 to 45%,
anaerobic association in 55 to 65%, pathological fungi in 50 to 60%. The
patients with type 2 diabetes had much more time from the onset of the
first symptoms of lung disease prior to admission (12.5 ± 3.5 vs. 7.5 ± 2.5
days, P = 0.002), and the duration of inpatient treatment was significantly
longer (13.8 ± 5.5 vs. 7.1 ± 3.4 days, P = 0.001). Only 53 (36.8%) of patients
with type 2 diabetes and 68 (29.5%) without it had bacteriological positive
blood culture. The analysis of the distribution of pathogens in groups is
presented in Figure 1. Patients with diabetes had more Candida spp.
Table 2(abstract P6) Cardiovascular comorbidity in
patients with type 2 diabetes before and after purulent-







Insulin dependence 42 (37.5) 112 (100)
Normal blood pressure (110 to 139
mmHg)
46 (41.1) 11 (9.8)
Arterial hypertension 66 (58.9) 88 (78.6)
First degree (140 to 159 mmHg) 33 (29.5) 21 (8.9)
Second degree (160 to 179 mmHg) 21 (18.6) 43 (38.4)
Third degree (>180 mmHg) 12 (10.7) 24 (21.4)
Arterial hypotension (<90 mmHg) - 13 (11.6)
CAD, stable angina 108 (94.6) 82 (73.2)
FC I 18 (16.1) -
FC II 29 (25.9) 18 (16.1)
FC III 52 (46.4) 45 (40.2)
FC IV 9 (8.0) 19 (17.0)
CAD, unstable angina 4 (3.6) 17 (15.2)
Acute myocardial infarction - 13 (11.6)
Postinfarction cardiosclerosis 7 (6.3) 7 (6.3)
Atrial fibrillation 7 (6.3) 7 (6.3)
Supraventricular arrhythmia 3 (2.7) 12 (10.7)
Ventricular arrhythmia 14 (12.5) 36 (32.1)
Congestive heart failure 112 (100) 112 (100)
FC II (NYHA) 76 (67.8) 26 (23.2)
FC III (NYHA) 36 (32.1) 65 (58)
FC IV (NYHA) - 21 (18.7)
Abscesses of the lower extremity - 22 (19.6)
Phlegmon of the lower extremity - 31 (27.7)
Gangrene of lower extremity - 59 (52.7)
Data presented as n (%). CAD, coronary artery disease; FC, functional class;
NYHA, New York Heart Association
Table 1(abstract P7) Clinical symptoms and severity of
sepsis in patients with acute purulent destructive







Acute lung abscess 59 (40.9) 122 (46.2)
Necrotizing pneumonia 47 (32.6) 98 (37.1)
Lung gangrene 38 (26.4) 44 (16.7)
Empyema 88 (61.1) 81 (30.7)
Pyopneumothorax 16 (11.1) 9 (3.4)
Mediastinitis 34 (23.6) 16 (6.1)
Body temperature >38°C/<36°C 98 (68.1)/21
(14.6)
261 (98.9)/3 (1.1)
Respiratory rate >20/minute 144 (100) 264 (100)
Heart rate >90 beats/minute 138 (95.8) 242 (91.7)







Renal failure, oliguria 42 (29.2) 34 (12.9)
Increase liver enzymes 34 (23.6) 45 (17.1)
Systolic blood pressure <90 mmHg 33 (22.9) 51 (19.3)
Sepsis 101 (70.1) 223 (84.5)
Severe sepsis 25 (17.4) 29 (11.0)
Septic shock 18 (12.5) 12 (4.5)
Data presented as n (%)
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(Figure 1). Figures 2, Figure 3 and Figure 4 present the X-ray dynamics of a
42-year-old man with lung abscess. Clinical recovery in patients with type
2 diabetes was significantly worthy compared to controls (45 (31.2%) vs.
153 (57.9%)), mortality rate 48 (33.3%) versus 39 (14.7%), respectively.
Conclusion: In patients with acute purulent destructive pulmonary
disease and type 2 diabetes, severe sepsis and septic shock more often
prevailed, inpatient mortality rate was 2.27 times higher, compared to
patients with normal glucose metabolism.
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Introduction: Mediastinitis is a life-threatening condition, which is
accompanied by high rates of mortality in cases of delayed diagnosis and
inadequate treatment. The aim of the study was to identify the risk
factors and incidence of mediastinitis in patients with lung abscess and
sepsis.
Methods: In 2013, 218 consecutive patients (83 women and 135 men)
with lung abscess and sepsis aged 45.8 ± 13.2 years were operated. They
had a full range of laboratory and instrumental examinations, including
echocardiography and computed tomography.
Results: Aerobic-anaerobic association in sputum was revealed in all
patients with lung abscess and sepsis, Candida spp. in 34 (15.6%). Blood
culture was positive only in 59 (27%) patients, which had not previously
received antibacterial therapy (polymicrobial flora including Staphylococcus
and Streptococcus specimen). Empyema was diagnosed in 123 patients
(56.4%), 31 (14.2%) of them were complicated by mediastinitis. The
main clinical symptoms of mediastinitis were hyperthermia (100%),
dysphagia (83.8%), dyspnea (80.6%), chest pain (61.3%), orthopnea
Figure 1(abstract P7)
Figure 2(abstract P7) Man, 42 years old, with right lung abscess after
admission to the centre
Figure 3(abstract P7) The same patient on the fourth day after
drainage of the abscess
Figure 4(abstract P7) The same patient before discharge, 14 days
in dynamics
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(61.3%), and tachycardia (87.1%). The computer tomography revealed
an increase in mediastinum size with accumulation of fluids and fluid in
the pleural cavities (100%), free gas in the mediastinum (45.1%),
enlarged mediastinal lymph nodes (45.1%), and fluid in the pericardium
cavity (48.4%). To analyze the risk factors, we include 31 patients with
lung abscess and sepsis complicated by mediastinitis in the first group,
and 187 patients without mediastenitis in the second group. Groups
were similar in age (46.1 ± 8.2 years vs. 45.8 ± 13.2 years). A total
77.4% of patients with mediastinitis were women who suffered from
type 2 diabetes (HbA1c = 9.7 ± 1.4%), congestive heart failure and
anemia. Significant differences in the groups according to the data of
laboratory and instrumental studies are presented in Table 1.
Conclusion: In total, 14.2% of patients presented with lung abscess and
sepsis complicated by mediastinitis, more commonly in women with diabetes
mellitus, obesity, anemia and reduced ejection fraction of the left ventricle.
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Introduction: The minimal biological active structure of endotoxins
(lipopolysaccharides (LPS)) is Re-LPS (KDO2-lipid A), which consist of lipid
A and two (or three) molecules of 3-deoxy-D-manno-2-octulosonic acid
(KDO) [1,2]. Biological activity of endotoxins is defined in general by the
number and distribution of acyl residues on the lipid A backbone [3].
Recently it has been reported that KDO-treated RAW 264.7 cells exhibited
a gene expression pattern similar to that in LPS-treated cells. These
authors revealed that free KDO participated in crosstalk between Toll-like
receptors (TLR) and G protein-coupled receptors and so that regulated
activators and repressors of immune signaling [4]. LPS-dependent
TLR4-triggered activation of target cells leads to specific changes in the
levels of surface receptors and induces synthesis of proinflammatory
cytokines [5]. However, the dependence of these processes on the
structural composition of LPS is not well understood. To extend our
knowledge in this field, the effects of free KDO as well as KDO as
covalently linked to lipid A constituent of Re-LPS on expression of TLR4,
CD11b and CD14 receptors and TNFa synthesis in whole human blood
have been investigated.
Methods: Human blood was incubated with Re-LPS from Escherichia coli
JM103 or Salmonella enterica sv Typhimurium SL1181 (100 ng/ml) or with
lipids A from E. coli F583 or S. enterica sv Minnesota R595 (80 ng/ml) or
with ammonium salt of KDO (20 ng/ml) at 37°C in 5% CO2-humidified
atmosphere for 2 or 6 hours to determine receptor expression or TNFa
release, respectively. Receptor expression was monitored by EPICS
XL-MCL flow cytometer using Alexa Fluor 488 anti-TLR4 (HTA125),
anti-CD11b (ICRF44) and anti-CD14 (HCD14) antibodies. Human TNF-a
ELISA Kit II was exploited to TNFa determination.
Results: Re-LPS E. coli or Re-LPS S. enterica differentially affected receptor
expression in comparison to their respective lipids A. Free KDO in the
equimolar concentration as it exists in KDO2-lipid A (Re-LPS) did not
influence the level of CD14 but downregulated the expression of TLR4 and
CD11b (Figure 1). Tenfold increased KDO concentration did not affect
further the receptor expression. The addition of KDO2 to lipid A E. coli - that
is, applying KDO as covalently linked constituent of Re-LPS - led to
upregulation of CD14 and TLR4 but downregulated CD11b expression. The
expression of TLR4 was most pronounced upregulated by Re-LPS S. enterica
but in the case of CD14 and CD11b this Re-LPS had an opposite effect in
comparison to E. coli endotoxins (table in Figure 1). Lipid A S. enterica was a
less potent TNFa inductor than that from E. coli (Figure 2). This may be
explained by the differences in lipid A composition determining lipid A
affinity to target receptor(s). LPS E. coli, as had been shown early, caused
MyD88-dependent fast NF-B degradation (rapid TNFa response) whereas
LPS S. enterica induced MyD88-independent signaling (delayed TNFa
response) [5]. In our study, free KDO did not stimulate TNFa release. KDO2
as a constituent of Re-LPS S. enterica increased significantly the TNFa-
inducing activity of lipid A S. enterica but this effect was not so distinguished
between Re-LPS E. coli and lipid A E. coli (Figure 2).
Conclusion: Free KDO in the used concentration was inactive in
regulation of TLR4, CD11b and CD14 expression and did not induce TNFa
release but its impact in biological activity was detected when KDO was
applied as constituent of Re-LPS. This may be explained by the effect of
KDO on the spatial conformation of Re-LPS.
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Figure 1(abstract P9) Expression of TLR4, CD11b and CD14 on
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Introduction: The purpose of this study was to verify the predictive value
of two novel formulae and compare them with that of procalcitonin (PCT)
for predicting sepsis in trauma patients.
Methods: We performed a retrospective study of trauma patients treated at
Daping Hospital in Chongqing, China and Affiliated Hospital of Zunyi
Medical College between 2010 and 2013. Patients ≥16 years old, admitted
to hospital after injury within 24 hours and with length of hospital stay ≥48
hours were included. Predictive ability of two formulae based on LD50 values
of the Injury Severity Score (ISS) and New Injury Severity Score (NISS) were
verified: ISS/LD50ISS+SIRS score and NISS/LD50NISS+SIRS score, and then
were compared with the most common used biomarker PCT. LD50 values for
different age groups and genders were obtained in our former study. The
statistical performance of the two formulae and PCT to predict sepsis was
evaluated using receiver operating characteristic (ROC) curve analysis.
Results: Two hundred and twenty-one trauma patients’ data were enrolled
in the study, including 44 females and 177 males. The average age of the
patients was 44.77 ± 15.01 years. The performance of the ISS/LD50ISS+SIRS
score and the NISS/LD50NISS+SIRS score was equivalent (area under the ROC
curve (AUC) = 0.816 vs. 0.819, P >0.05) and both performed better than PCT
(AUC = 0.592, P < 0.05) in predicting posttraumatic sepsis. For the ISS/
LD50ISS+SIRS score, the cutoff value was 2.38, with a positive predictive
value of 78.08%, a negative predictive value of 81.33%, a sensitivity of
89.06%, a specificity of 65.59%, a positive likelihood ratio of 2.59, a negative
likelihood ratio of 0.17, a Youden index of 0.5465, an odds ratio of 15.52,
and an accuracy of 79.19%. For the NISS/LD50NISS+SIRS score, the cutoff
value was 2.4677, with a positive predictive value of 79.70%, a negative
predictive value of 75.00%, a sensitivity of 82.81%, a specificity of 70.97%, a
positive likelihood ratio of 2.85, a negative likelihood ratio of 0.24, a Youden
index of 0.5378, an odds ratio of 11.78, and an accuracy of 77.83%.
Conclusion: The two novel formulae ISS/LD50ISS+SIRS score and NISS/
LD50NISS+SIRS score performed well and were both better than PCT in
predicting sepsis post trauma. The value of the two formulae can be
easily calculated in real time and can identify the high-risk patients
susceptible to sepsis. This method may become an effective way to guide
the early assessment and treatment in trauma patients.
P11
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inactivation of NF-B by inhibiting IBa phosphorylation.
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Introduction: Inflammation is a host defense reaction against pathogenic
infection. In this process, inflammatory cytokines contribute to combat
against infection, but excess cytokines will lead to tissue damage.
Nonsteroidal anti-inflammatory drugs and corticosteroids are commonly
used for regulating these inflammatory mediators and treatment of
inflammatory disorders. But these drugs are not sufficient for clinical
practice due to their adverse effects, so new anti-inflammatory drugs are
still needed. Evodiamine (EVO), an important alkaloidal component
extracted from the fruit of Evodiae fructus, possesses the property of
analgesia, antiemesis, and vascular dilatation. Its anti-inflammatory effect
and underlying mechanism were investigated using a zymosan-induced
inflammatory model.
Methods: In vitro, RAW264.7 cells and primary peritoneal macrophages
were treated with different doses of EVO (25, 50 or 100 μM) for 1 hour
prior to incubation with zymosan (100 μg/ml), and the effects of EVO on
protein and mRNA levels of proinflammatory cytokines were determined
by ELISA and qRT-PCR, respectively. In vivo, peritonitis was induced in
C57BL/6 mice by zymosan (500 mg/kg) injection, and the effects of EVO
(10 mg/kg) on plasma cytokine levels and organ injury were evaluated.
Activation of the NF-B signal pathway was investigated by ELISA-based
Trans-AM transcription factor NF-B p65 kit, immunocytochemistry and
western blotting.
Results: EVO effectively suppressed the expression of IL-1b, IL-6 as well
as TNFa in both protein and mRNA level in vitro. It can also attenuate
zymosan-induced DNA-binding activity of NF-B, which was achieved
through the inhibitory effects on the phosphorylation of inhibitory kappa
B a (IBa) and p65 nuclear translocation, but there was little association
with mitogen-activated protein kinase activation. In vivo, treatment with
EVO could ameliorate inflammatory cell infiltration and vascular ectasia
induced by zymosan in both lung and intestine tissues. EVO can
markedly decrease the level of TNFa and IL-6 in plasma, and effectively
downregulate expression of IL-6, TNFa and myeloperoxidase in both lung
and intestine. Moreover, cell apoptosis in organs was also attenuated by
treatment of EVO. The underlying mechanism that a decrease in the
phosphorylation of IBa and the subsequent transcription activity of
NF-B was also confirmed.
Conclusion: Taken together, our data demonstrate that EVO displays anti-
inflammatory actions in vitro and in vivo by suppressing the phosphorylation
of IBa and inactivating NF-B, which suggests that EVO is a potential
therapeutic agent against inflammatory disorder.
P12
Imaging in severe sepsis and septic shock: is early radiological
identification of occult sources of infection needed?.
A Creamer*, J Keep
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Critical Care 2014, 18(Suppl 2):P12; doi:10.1186/cc14015
Introduction: The importance of imaging in establishing the focus of
infection is recognised in current guidelines for the management of severe
sepsis [1], with decisions regarding timing and modality of imaging left to
the physicians’ clinical judgement. In the emergency department (ED),
clinical assessment combined with bedside investigations of chest X-ray
Figure 2(abstract P9) Production of TNFa after incubation of whole
blood with lipid A or Re-LPS
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(CXR) and urine dip can be used to confirm the two most common sources
[2]. However, they may fail to identify occult sources of infection, such as
intraabdominal collections and abscesses, the treatment of which may
require alteration of empirical treatment or be refractory to antibiotic
therapy alone. Further imaging is necessary to confirm the focus so that
optimal treatment can be achieved.
Methods: The study cohort was composed of 50 consecutive patients who
met the criteria for severe sepsis [1] attending the ED in 2013. Electronic and
paper patient records and radiology results were analysed. All radiological
studies done in the first 72 hours following attendance were included in the
study.
Results: CXR was performed as the initial investigation in 49 of the 50
patients (98%). The median time from arrival at the ED to initial imaging was
1 hour:00 minutes (range 0 hours:04 minutes to 4 hours:25 minutes). Initial
investigations in the ED of CXR and urine dip identified a septic focus in
30 of 50 patients (60%). Fourteen of the remaining 20 went on to have one
or more further imaging studies. Figure 1 outlines the second-line and third-
line radiological investigations performed (number where a septic focus was
identified in parentheses). The median time to first positive imaging was 0
hours: 50 minutes (range 0 hours:04 minutes to 40 hours), with the source
remaining unidentified by imaging and urine testing in 15 of the 50 patients.
Conclusion: Our results indicate that simple bedside investigations are able
to identify a focus of infection in 60% of patients presenting to the ED with
severe sepsis. Our results support the continued use of CXR as the initial
imaging modality in severe sepsis, but also demonstrate the benefit of
further imaging in confirming the focus of infection and to guide definitive
treatment. Instances where further imaging was delayed by several days
highlight the need for guidelines detailing which investigations should be
done and in what time frame.
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Introduction: Despite improvements in supportive care, mortality rates in
sepsis remain substantially high. Sepsis exhibits phases of enhanced
inflammation, alternating with immune suppression with a resultant variant
time point of mortality; yet no human study has correlated levels of
cytokines to the timeline of mortality. Our study attempts to analyze the
association of levels of proinflammatory and anti-inflammatory cytokines in
sepsis with the timeline of death in terms of early (<5 days) versus late
(>5 days) mortality, and day of death. We also assessed correlation of these
cytokines with length of stay.
Methods: The study protocol was approved by Institutional Ethics
Committee. Subjects were 74 consecutive patients with community-
acquired severe sepsis/septic shock admitted to the ICU of a tertiary care
superspeciality hospital. Blood samples drawn on days 1, 3 and 7 of
admission were analysed for proinflammatory cytokine (TNFa) by
chemiluminescent immunometric assay and anti-inflammatory cytokine (IL-10)
by ELISA. Subjects were segregated on basis of: ratio of proinflammatory and
anti-inflammatory mediators on day 1 of admission into patients with
predominant proinflammatory or predominant anti-inflammatory response.
Survival and time point of mortality into survivor, early mortality and late
mortality groups. Statistical analyses were performed using SPSS version 17.
Results: There were 37 patients each in predominant proinflammatory and
predominant anti-inflammatory groups. The number of deaths was 11 and
17 respectively in these groups. However, there was significantly higher
early mortality in the proinflammatory group as compared to the anti-
inflammatory group (7 vs. 1, P = 0.0247). On the contrary, late deaths were
significantly higher in the anti-inflammatory group as compared to the
proinflammatory (16 vs. 4 P = 0.0017). The ratio of proinflammatory/anti-
inflammatory cytokines (TNF/IL-10) on day 1 was significantly lower in
patients of late death (n = 20) as compared to patients of early death (n = 8)
and survivors (n = 46) as shown in Table 1. Further, the median day of death
Figure 1(abstract P12) Initial and further investigations performed (number where a septic focus was identified in parentheses)
Critical Care 2014, Volume 18 Suppl 2
http://ccforum.com/supplements/18/S2
Page 9 of 53
was significantly delayed in patients in the anti-inflammatory as compared
to the proinflammatory group (20 vs. 5, P < 0.001). Length of hospital stay
amongst survivors was significantly longer in the anti-inflammatory as
compared to the proinflammatory group (23 vs. 10 P < 0.001).
Conclusion: Our preliminary data suggest that in sepsis, the ratio of
proinflammatory/anti-inflammatory cytokines on day 1 is significantly
associated with time point of mortality; hence, this ratio can be used to
particularize management. Further studies are in progress to substantiate
the role of proinflammatory and anti-inflammatory cytokines in this
subset of patients. Moreover, since predominant anti-inflammatory
response was associated with later death, role of immunomodulators in
sepsis needs to be explored.
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Introduction: Invasive Staphylococcus aureus infections remain an unmet
medical need with the issues of drug resistance (MRSA) and mortality.
Understanding clinical trial data in the development of antibiotics to
S. aureus is complicated by heterogeneous clinical outcomes (that is,
length of hospitalization, mortality, treatment response), which makes
interpretation of drug efficacy challenging. Identification of prognostic
biomarkers of different biological processes that associate with clinical
outcomes would aid in clinical development of novel therapies for
S. aureus infections.
Methods: In an effort to discover biomarkers that differentiate patient
populations based on clinical outcomes following S. aureus infection, we
retrospectively analyzed published gene expression datasets of S. aureus
infection and sepsis.
Results: We identified a leukocyte gene expression signature that positively
correlated with S. aureus disease severity [1]. This severity signature was
enriched for genes associated with neutrophils but was not solely explained
by increased percentage of neutrophils. This set of genes was also associated
with severity in sepsis, with higher expression in patients with septic shock
compared with sepsis [2] and in nonsurvivors compared with survivors of
septic shock [3]. Our in vitro studies revealed that the severity signature may
reflect an increase in circulating immature neutrophils or band cells which
has been previously reported in the context of bacterial stimuli and sepsis
[4,5]. This line of evidence is consistent with a recent report by Guerin and
colleagues that demonstrated that quantification of immature neutrophils by
flow cytometry was prognostic for sepsis mortality [6].
Conclusion: To extend the insight gained from our retrospective analysis
and in vitro studies, we are conducting a longitudinal, non-interventional
clinical study of patients with S. aureus bacteremia. The goal of the study is
to associate molecular metrics (gene expression, plasma protein levels,
immune cell subsets) with clinical outcomes (length of hospitalization,
mortality, treatment response, readmission for recalcitrant infection). Our
preliminary data show an association between grade of sepsis or infection
localization and increased immature neutrophils as well as monocyte
subsets that can promote inflammation or immune exhaustion. Ongoing
experiments are designed to understand the impact of these cellular
phenotypes on disease progression and to identify robust protein or RNA
biomarkers that are prognostic for clinical outcomes.
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Introduction: Autophagy could be induced under stress conditions,
including starvation, infection, and hypoxia. The microRNA (miRNA)
network may be critical in the regulation of autophagy. Upregulation of
autophagy may be a protective response for cell survival in ischemic
kidney injury. The aim of this study was to evaluate whether miRNA
regulates autophagy in ischemic kidney injury and renal proximal tubular
cells under hypoxic conditions.
Methods: Ischemic kidney injury was performed by clamping bilateral
renal pedicles for 60 minutes in male mice. Human kidney proximal
tubular (HK2) cells are incubated in a hypoxic chamber with 0.3% O2.
Bioinformatics analyses were used to select the candidate miRNA. Gain-
of-function and loss-of-function methods were employed to evaluate the
effects of miRNA on autophagy. Chromatin immunoprecipitation analyses
and promoter luciferase reporter assays were used to evaluate the
interaction of transcriptional factors with miRNA.
Results: Increase of LC3 and ATG16L1, autophagy-related proteins, and down
expression of miR-20a-5p were detected in kidneys after ischemic injury and
in HK2 cells under hypoxic conditions. The 3’-untranslated region luciferase
reporter assays indicated that miR-20a-5p targeted ATG16L1 messenger RNA.
Overexpression of miR-20a-5p reduced the expression of LC3-II and ATG16L1
in HK2 cells under hypoxic conditions, whereas antagomiR-20a reversed the
inhibition. Using RNAi against hypoxia-inducible factor-1a (HIF-1a) in HK2
cells, we confirmed the inhibitory binding of HIF-1a to miR-20a-5p.
Conclusion: The signaling axis of HIF-1a, miR-20a-5p, and ATG16L1 in
autophagic process might be a critical adapting mechanism for ischemic
kidney injury.
Table 1(abstract P13) TNF/IL-10 ratio in study groups at different time points
Early death (≤ 5 days) (n = 8) Late death (>5 days) (n = 20) Survivors (n = 46) P value
Day 1 1.81 (1.00 to 3.44) 0.50 (0.31 to 0.90) 1.22 (0.43 to 3.91) 0.020*
Day 3 1.12 (0.50 to 3.91) 1.01(0.20 to 2.21) 2.5 (0.90 to 3.91) 0.158
Day 7 - 1.25 (0.59 to 2.38) 1.79 (0.75 to 3.90) 0.256
Data presented as median (IQR). Kruskal-Wallis test was performed for significance between three groups. *P < 0.05 considered significant
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Introduction: Since the initial development of the Surviving Sepsis
Campaign guidelines outlining the management of severe sepsis, there
has been an absolute discount on the management of septic patients in
medical surgical units. In efforts to improve severe sepsis, a community
hospital in Miami adopted a severe sepsis screening tool (SSST) to rapidly
identify severe septic patients in medical surgical units. A pilot study was
conducted to evaluate the sensitivity and specificity of the SSST.
Methods: A descriptive retrospective study. There were two phases. Phase 1
evaluated the percentage of patients with sepsis criteria utilizing the SSST.
Patients admitted to 4 Tower during 2013 presenting with a diagnosis of
sepsis syndrome and admitted to 4 Tower presenting without sepsis
syndrome were reviewed. Phase 2 evaluated the sensitivity and specificity of
SSST from August 2013 to January 2014. Total number of patients admitted
to 4 Tower: of those patients, total number with discharge diagnosis of
sepsis, total number who screened positive >1 time during hospital stay,
and total number who screened negative during hospital stay; there were
five missing cases. The receiver operating curve (Figure 1) and the
respective area under the curve were calculated. Utilizing a 2 × 2 design, the
sensitivity and specificity of the tool was calculated.
Results: Phase 1: a total of 220 patients records were reviewed, a
frequency distribution was utilized (Table 1), demonstrating that the SSST
identified those patients with sepsis criteria 76 % (n = 167) of the time.
Phase 2: a total of 1,555 patients were included during phase 2. A 2 × 2
design (Table 2) was utilized: 78 patients were identified as true positive
and 1,233 patients were identified as true negative. The study yielded a
sensitivity of 41.49% and a specificity of 90.53%. The positive predictive
value of the tool was estimated at 37.68%, negative predictive value was
estimated at 91.81% and disease prevalence was 12.13%. Area under the
receiver operating curve (Table 3) was 0.66.
Conclusion: A two-phase retrospective chart review study demonstrated
that the SSST utilized at a community hospital in Miami had a sensitivity
value of 41.49% and a specificity value of 90.53% when evaluating medical
surgical patients. These results indicate the tool is accurate in detecting
patients that are not septic; however, it is not reliable in identifying patients
who are truly septic. Further studies need to be conducted to validate the
sensitivity and specificity of the SSST; changes will be recommended in an
effort to improve sensitivity.
Acknowledgements: Thanks to Eve Butler and Andrea Prentiss from
Baptist Research Department, 4 Tower team. Special thanks to Melanie
Santos, Luz Lorenzo, Disney Granado, Katiuska Diaz, Sandra Benitez,
Magdely Perez, Viviana Castillo and Ofelia Cabrera.
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Introduction: Compliance with the Surviving Sepsis Campaign 2012 (SSC)
bundle in the emergency department (ED) is a key point to improve
outcome of severe sepsis and septic shock [1,2]. Before and after
education of ED staff, we registered compliance and timing of lactate
dosing, blood culture sampling, empiric antibiotic therapy (ATB) and fluid
resuscitation, the 3-hour (H3) bundle. Survival and compliance according
to the initial pathway of care were also studied.
Methods: A monocentric study before and after education of ED staff
about SSC bundles (courses, posters, pocket guides). We looked at
compliance of the H3 bundle items in a retrospective and a prospective
cohort, timing of realisation, day 28 survival, overall severity (SAPS2, SOFA
and RISCC scores), impact of prehospital medical management, and initial
pathway of care. Statistical analysis was performed with Fisher exact test
and Mann-Whitney test. Multivariate analysis of factors associated with
survival was made through logistic regression.
Results: Eighty-nine patients were included in the prospective cohort, 65
in the retrospective cohort. Patterns of patients in the retrospective and
prospective cohort were respectively: sex ratio M/F 29/39 and 39/47 (NS);
Figure 1(abstract P16) ROC curve
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median age 63.29/61.38 (NS); SAPS2 44/40 (P = 0.019); SOFA 4/3 (P =
0.005); RISCC 9/12.5 (P = 0.002). Compliance with the H3 bundle items
before and after intervention was: lactate 72.1% vs. 81.4% (NS); blood
cultures 61.8% vs. 67.4% (NS); ATB 29.3% vs. 52.3% (P = 0.005); fluids
52.9% vs. 59.3% (NS). Median delays before and after implementation
were (in minutes): lactate 56 vs. 40 (P = 0.024); blood cultures 68 vs. 75
(NS); ATB 229 vs. 160 (NS); fluids 100 vs. 74 (NS). Survival was superior
after intervention 67.6 vs. 81.4% (P = 0.049), and associated with a low
SAPS2 score in multivariate analysis. Admission through a prehospital
medical team was associated with a stronger H3 ATB compliance before
intervention (P = 0.032). Within the ED, initial orientation to the acute
care unit was associated with a better H3 ATB compliance compared to
standard care before and after staff education (P = 0.001; P = 0.003), and
with better overall compliance (P = 0.004; P = 0.026).
Conclusion: Compliance with the SSC H3 bundle was increased but still
needs to be improved. There is an impact of the initial pathway of care
on compliance of the bundle, and on timing of ATB injection. Differences
in healthworker/patient ratio in the units of care could explain these
disparities [3]. Improvement could be obtained through optimizing early
screening, correct initial guidance, or with dedicated teams.
Acknowledgements: The authors would like to thank the members of
the Unit of Clinical Research of the Hospital Center of Lens for their great
help in data recovery
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Introduction: In severe sepsis and septic shock patients, lactate clearance
>10% and central venous oxygen saturation (ScvO2) >70% are accepted
parameters of tissue oxygenation adequacy. There is controversy of which
parameters better associate with early mortality, and thus should be
implemented as the microcirculation end point resuscitation [1-3]. This
study was aimed to address the association of achieving either one or
two targets of microcirculatory end point resuscitation and early mortality
in severe sepsis and septic shock patients.
Methods: A retrospective cohort study was conducted in severe sepsis
and septic shock patients (aged 18 years and older) hospitalized in the
ICU, Cipto Mangunkusumo Hospital, Indonesia. Patients’ early outcomes
were observed during first 120 hours of hospitalization. Cox’s regression
analysis was used to analyse risk of early mortality in subject groups
achieving lactate clearance target only, ScvO2 target only, both targets,
and not achieving any target in 6 hours after onset of resuscitation.
Results: Subjects consisted of 268 patients. Early mortality developed in
70 subjects. Fifty-four subjects achieved lactate clearance target only, 16
achieved ScvO2 target only, 138 achieved both targets, 60 did not
achieve any target. Subjects who achieved both targets had a significant
lowest early mortality risk (P = 0.104 compared with subjects achieved
lactate clearance target only and P = 0.000 compared with remaining
subject groups) (Figure 1). In subgroup analysis of subjects who achieved
lactate clearance or ScvO2 target only, failure to achieve lactate clearance
target associated with higher early mortality risk (hazard ratio 5.92; 95%
CI 2.18 to 16.01).
Conclusion: Achieving both lactate clearance and ScvO2 targets in
6 hours after onset of resuscitation associates with lowest early mortality
risk in severe sepsis and septic shock patients. Patients who achieve
lactate clearance target only have a significant lower early mortality risk
compared with those who achieve ScvO2 target only.
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Table 1(abstract P16) Frequency distribution
Statistics Diagnosis on admission Sepsis tool identifies sepsis
Valid 220 220
Missing 0 0
Frequency table Frequency Percent Valid percentage Cumulative percentage
Diagnosis on admission
Valid 220 100.0 100.0 100.0
Sepsis tool identifies sepsis
Not valid 53 24.1 24.1 24.1
Valid 167 75.9 75.9 100.0
Total 220 100.0 100.0
Table 2(abstract P16) The 2 × 2 design
Sepsis present Sepsis absent
Positive 78 true positive 129 false positive
Negative 110 false negative 1,233 true negative
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Introduction: Many patients present with sepsis through emergency
services [1]. Their outcome could be improved if sepsis could be detected
already in the prehospital setting. This study aims to develop and
evaluate a score to detect prehospital early sepsis.
Methods: A retrospective study of 375 patients admitted to Jena
University Hospital emergency department (ED) through emergency
medical services (EMS). Sepsis was present in the ED in 93 (24.8%)
patients, of which 60 (16.0%) had severe sepsis and 12 (3.2%) had septic
shock. The following predictors for sepsis based on consensus criteria
were extracted from the EMS protocol: body temperature (T), heart rate
(HR), respiratory rate (RR), oxygen saturation (SaO2), Glasgow Coma Scale,
blood glucose and systolic blood pressure (BP). Sepsis predictors were
determined based on inspection of loess graphs. Backward model
selection was performed to select risk factors for the final model. The
PRESEP score was calculated as the sum of simplified regression weights.
Its predictive validity was compared to the modified Early Warning Score
(MEWS) [2], the Robson screening tool [3] and the BAS 90-30-90 [4].
Results: Backward model selection identified T, HR, RR, SaO2 and BP for
inclusion in the PRESEP score. Its AUC was 0.93 (CI 0.89 to 0.96). The
cutoff based on maximum Youden’s Index was ≥4 (sensitivity 0.85,
specificity 0.86, PPV 0.66, NPV 0.95). The PRESEP score had a larger AUC
than the MEWS (0.93 vs. 0.77, P < 0.001) and surpassed MEWS and BAS
90-60-90 concerning sensitivity (0.74, 0.62), specificity (0.75, 0.83), PPV
(0.45, 0.51) and NPV (0.91, 0.89). The Robson screening tool had a higher
sensitivity and NPV (0.95, 0.97) was better, but its specificity and PPV
lower (0.43, 0.43).
Conclusion: The PRESEP score can be easily applied in the emergency
setting and could be a valuable tool to identify septic patients in the
case of suspected infection.
Acknowledgements: OB was supported, in part, by an unrestricted grant
of the Thuringian Ministry of Cultural Affairs (Landesprogramm
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Introduction: Sepsis is one of the leading causes of death around the
world. The failure of clinical trials to treat sepsis demonstrates that
the molecular mechanisms are multiple and still insufficiently understood.
The objective is to clarify the long disputed hierarchical contribution of
several central inflammatory mediators, namely IL-1b, IL-18, CASP7, CASP1
and CASP11, in septic shock, and to explore their therapeutic potential.
Methods: LPS-induced and TNF-induced lethal shock, as well as cecal ligation
and puncture (CLP), were performed in genetically or pharmacologically
targeted mice. Body temperature and survival were monitored closely, and
plasma was analyzed for several markers of cellular disintegration and
inflammation.
Results: Interestingly, deficiency of both IL-1b and IL-18 additively
prevented LPS-induced mortality. The detrimental role of IL-1b and IL-18
was confirmed in mice subjected to a lethal dose of TNF, or to a lethal CLP
procedure. Although their upstream activator, CASP1, and its amplifier,
CASP11, are considered potential therapeutic targets because of their crucial
involvement in endotoxin-induced toxicity, CASP11 or CASP1/11 deficient
mice were not, or hardly, protected against a lethal TNF or CLP challenge. In
line with our results obtained in genetically deficient mice, only the
combined neutralization of IL-1 and IL-18, using the IL-1 receptor antagonist
Anakinra and anti-IL-18 antibodies, conferred complete protection against
endotoxin-induced lethality.
Conclusion: Our data point towards the therapeutic potential of
neutralizing IL-1 and IL-18 simultaneously in sepsis, rather than inhibiting
the upstream inflammatory caspases.
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Introduction: Severe sepsis and septic shock (SS/SS) have a high
mortality. Therapeutic guidelines can improve mortality, but early
recognition and timely implementation of these requires a proactive
attitude that can be electronically supported.
Methods: From May 2013 our hospital implemented a Sepsis Code
(SC) based on an early detection electronic rule developed by our
multiprofessional sepsis team: clinicians and IT engineers (EMR Cerner
Millennium platform) and a standardized order set plus systematic follow-up
by our sepsis team. We performed a before-after study to assess the impact
over mortality of this strategy. Time-series analysis of sepsis admissions and
mortality from January 2011 to December 2013, before and after SC
implementation. (Analysis by STATA.) All urgent admissions recorded in the
minimum basic data set in patients over 14 years from 1 January 2011 to 31
December 2013 were included. Inclusion criteria: patients with ICD-9 sepsis-
associated codes in the principal diagnosis or patients with infection-
associated codes in the principal diagnosis together with sepsis-associated
codes in secondary diagnosis. Medical records were manually reviewed by
clinicians to confirm SS/SS diagnosis. Temporal series analysis (Poisson
regression). First analysis: sepsis admissions in relation to total urgent
admissions. Second analysis: deaths due to SS/SS related to admissions in
this group. In both cases we compared results before SC activation
(28 months) and after that (first 2 transitional months and 6 consolidated
months). The multivariate adjustment in both analyses included year, month
of the year, and months with activated rule. Graphic analysis estimated
predictions for the last 8 months based on the previous 28 months,
comparing both observed and predicted sepsis and deaths.
Results: A total of 24,118 urgent admissions were included, 5,657 in the
postalert period. Mean monthly admissions: 652 (SD 47) (570 to 740). In total,
408 and 178 SS/SS were identified in the prealert and postalert period,
respectively. After SC implementation we observed no significant changes in
sepsis admission risk but a clear downward trend in sepsis mortality: in the
first 2 transitional months we did not observe major changes, while in the
last 6 months the risk of death does fall 36% reaching statistical significance
(IRR 0.64 (95% CI 0.43 to 0.97, P = 0.036)) (Table 1 Figures 1 and Figure 2).
Both antibiotic door-to-needle time and adequacy significantly improved in
sepsis cases where the alert was triggered.
Conclusion: Implementation of a SC triggered by an electronic detection
alert, compared to the prealert period, decreased mortality risk by 36% (IRR
0.64 (95% CI 0.43 to 0.97, P = 0.036)) with the rule fully implemented.
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Introduction: In severe sepsis/septic shock (SS/SS), early recognition and
timely implementation of treatment is critical for survival, and this could be
electronically supported. We assess the value of an electronic automatic
algorithm based on EMR data as a screening tool for early detection of sepsis.
Methods: Our multiprofessional sepsis team (clinicians and IT engineers)
developed an electronic algorithm using data from our EMR (Cerner
Millennium platform) aimed at the automatic, real-time recognition of two
or more systemic inflammatory response syndrome components + one or
more organ failure parameter (according to sepsis definition) in every
patient attended in the ER. The firing of this sepsis rule issues an alert to the
responsible clinician to confirm an infectious etiology and opens an
electronic standardized order set according to sepsis bundles. The alert
database (from its start in May 2013 to December 2013) was cross-matched
with the minimum basic data set for urgent admissions (>14 years) during
this same period. We selected, based on an ad hoc syntaxes, those
admissions due to sepsis. Medical records were manually reviewed for
confirmation of SS/SS. We assessed sensibility, specificity, negative and
positive predictive value of the electronic rule, considering the confirmed
clinical diagnosis at discharge as the gold standard.
Results: In total, 37,323 patients were seen in the ER, 5,657 emergency
admissions took place and 178 were due to SS/SS. Alert fired in 1,190 (3.2%)
total emergencies and in 754 emergency admissions (13.3%). Data analysis
after alert implementation identifies a global sensitivity of 80%, which
improved after the first 2 months of transition. In the last 6 months
(consolidated period) it was between 85 and 90%. Global specificity 89%,
NPV of 99% and PPV of 19% for a global prevalence at admission of 3.2
cases/100 (Table 1). The mean door-to-alert time was 167 minutes (SD 193).
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Median door to needle (antibiotic) time in the alert-sepsis group was 259
minutes vs. 417 minutes in the group where alert did not fire. In the alert +
order set group, antibiotic treatment was adequate in 70% vs. 35% in the
nonalert sepsis group (Fisher’s exact = 0.001). Overall mortality among alert-
fired admissions not due to sepsis was 15% (RR for death during admission:
5.33, 95% CI: 3.73 to 7.59; P < 0.0001).
Conclusion: This pioneering sepsis algorithm identified 80% of SS/SS. The
alert prompted adequate antibiotic treatment and shortened door to needle
time from 7 to 4 hours. Furthermore, in patients without sepsis the algorithm
identifies a poor-prognosis subset (RR for death 4.75 (95% CI: 3.72 to 6.07).
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Introduction: Although there have been many clinical trials for treatment
of sepsis, no drugs are available at present. Sepsis is thought to be
complex disorders; activation/lesion of vascular endothelial cells,
accelerated coagulation and platelet aggregation, leukocyte activation or
paralysis, and hypercytokinemia. To treat the pathological status of sepsis,
it must be necessary to control these plural disorders simultaneously or
sequentially. In the present study, we identified and characterized a plasma
protein histidine-rich glycoprotein (HRG) as a factor that decreases
dramatically in septic condition and maintains neutrophil’s shape and
functional quiescence. We clarified the involvement of HRG in septic
pathogenesis and propose a novel therapy for sepsis based on that.
Methods: Sepsis was induced in mice by cecal ligation and puncture. The
mice were treated with HRG purified from human plasma after confirming
the marked decrease in plasma HRG. We evaluated the beneficial effects
of HRG administration on survival rate, lung inflammation, and the state
of circulating neutrophils using in vivo imaging. Purified neutrophils from
human blood were treated with HRG and analyzed with respect to
neutrophil shape, adhesiveness to vascular endothelial cells, passage
through microcapillaries, production of reactive oxygen species, and
cytoskeleton rearrangement with relevant signal transduction.
Results: Supplementary treatment of septic mice with exogenous HRG for
the decrease in plasma HRG improved the survival of mice remarkably. HRG
treatment reduced the number of neutrophils in the lung, on which platelet
aggregation and fibrin deposit were observed. HRG also inhibited the
expression of mRNAs of IL-6, TNFa, iNOS, and PAI-1 in the lung. In contrast,
knockdown of HRG by siRNA exacerbated lethality. Purified human HRG
reversibly induced morphological changes in human neutrophils in vitro;
induction of spherical shape with reduced microvilli and adhesiveness to
vascular endothelial cells. HRG maintained the passage of neutrophils
through microcapillaries and abolished the production of reactive oxygen
species whereas HRG had no effect on the expression of adhesion
molecules including CD11b and CD62L.
Conclusion: We show that plasma protein HRG is a crucial factor that
keeps the circulating neutrophils quiescent and prevents unnecessary
activation in bloodstream using a cecal ligation and puncture model in
Table 1(abstract P21) Risk of death in sepsis admissions
Variable Category IRR 95% CI P value
Month January 2.11 0.80 to 5.55 0.130
February 2.55 1.04 to 6.24 0.040
March 2.45 1.00 to 6.01 0.051
April 1.0 (reference)
May 2.24 0.86 to 5.88 0.100
June 1.45 0.53 to 4.01 0.470
July 2.15 0.82 to 5.66 0.121
August 2.62 1.00 to 6.85 0.050
September 3.74 1.47 to 9.53 0.006
October 2.31 0.89 to 6.02 0.085
November 2.69 1.09 to 6.65 0.032
December 1.89 0.71 to 5.01 0.203
Alert Previous 1.0 (reference)
Transition 1.26 0.64 to 2.47 0.506
Implemented 0.64 0.43 to 0.97 0.036
Figure 1(abstract P21) Emergency admissions for sepsis
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mice and human neutrophils. The attachment of neutrophils on the
vascular wall under reduced concentration of HRG was accompanied by
microthrombus formation in the lung, leading to ARDS. Supplementary
therapy with HRG may thus provide a novel strategy for the treatment of
septic patients through neutrophil regulation.
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Introduction: Intravenous immunoglobulin (IVIG) has been used as adjuvant
therapy for severe sepsis patients expecting the anti-inflammatory effect.
However, the effects of IVIG have been controversial. The majority of ill
patients with SIRS had coagulation abnormalities. In addition, inflammation
and coagulation play pivotal roles in the pathogenesis of sepsis. Moreover,
the evidence of extensive cross-talk between these two systems has been
increasing. The aim of this study is to investigate the effects of IVIG treatment
for inflammation and hemostatic abnormality in sepsis patients.
Methods: This prospective single-center observational study was
conducted in our ICU between January and July 2013. We enrolled
41 patients (≥18 years, admitted to the ICU diagnosed for sepsis, and
more than 7 days of ICU stay) and divided them into two groups: IVIG-
treated group (IVIG group) and non-IVIG-treated group (non-IVIG group).
After that, we compared inflammatory molecule markers (WBC, CRP,
procalcitonin (PCT), and interleukin-6 (IL-6)), coagulation/fibrinolysis
markers (platelet counts, PT-INR, APTT, D-dimer, TAT, PIC, soluble fibrin
(SF), and plasminogen activator inhibitor-1 (PAI-1)), and Japanese Association
for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) score
and positive rate at the admission period (day 1) and days 4 to 7 between
two groups. Moreover, the 28-day mortality rate was investigated.
Results: Nineteen patients were treated with IVIG (IVIG group) and 22
patients were without (non-IVIG group). In the IVIG group, PCT and IL-6 were
significantly higher than that in the non-IVIG group at day 1 (P < 0.01, and P <
0.01). In this group, CRP, PCT, and IL-6 were significantly decreased at days 4
to 7 rather than that at day 1 (P < 0.01, P < 0.01, P < 0.01, respectively).
Moreover, the JAAM DIC score was decreased at days 4 to 7 than that at day 1
significantly (P < 0.05) in this group. We also confirmed that PT-INR, APTT, TAT,
SF, and PAI-1 were significantly improved between day 1 and days 4 to 7. On
the other hand, in the non-IVIG group there was significantly decreased IL-6
and TAT only, but not CRP, PCT, PT-INR, APTT, SF, PAI-1 and JAAM DIC score
between day 1 and days 4 to 7. For the 28-day mortality rate, the IVIG group
was lower than that of the non-IVIG group (IVIG group, 5.3%; non-IVIG
group, 18.2%).
Conclusion: Our study demonstrated that IVIG treatment significantly
improved the inflammatory and hemostatic abnormalities in sepsis
patients.
Figure 2(abstract P21) Mortality in emergency admissions for sepsis
Table 1(abstract P22) Prevalence of SS/SS upon admission and sensitivity, specificity, and predictive values of the
sepsis rule
Month Prevalence Sensitivity Specificity PPV NPV
May 3.1 (1.8 to 4.5) 72.7 (51.8 to 93.6) 88.3 (85.8 to 90.7) 16.7 (8.7 to 24.6) 99.0 (98.1 to 99.9)
June 3.0 (1.6 to 4.3) 55.0 (30.7 to 79.3) 89.2 (86.7 to 91.6) 13.4 (5.4 to 21.4) 98.5 (97.4 to 99.6)
July 3.0 (1.7 to 4.3) 86.4 (69.8 to 100) 89.8 (87.5 to 92.1) 20.7 (11.8 to 29.5) 99.5 (89.9 to 100)
August 1.8 (0.8 to 2.8) 78.6 (53.5 to 100) 87.8 (85.4 to 90.2) 10.7 (4.2 to 17.1) 99.6 (99.0 to 100)
September 2.2 (1.0 to 3.4) 86.7 (66.1 to 100) 88.0 (85.4 to 90.5) 14.0 (6.4 to 21.6) 99.7 (99.1 to 100)
October 4.3 (2.7 to 5.9) 82.8 (67.3 to 98.2) 90.6 (88.3 to 92.9) 28.2 (18.1 to 38.4) 99.2 (98.3 to 100)
November 5.4 (3.5 to 7.2) 84.9 (71.1 to 98.6) 88.9 (86.2 to 91.5) 30.1 (20.3 to 40.0) 99.1 (98.1 to 100)
December 2.9 (1.6 to 4.2) 90.5 (75.5 to 100) 88.4 (85.9 to 90.8) 19.0 (10.8 to 27.2) 99.7 (99.1 to 100)
Total 3.2 (2.7 to 3.6) 80.1 (73.9 to 86.3) 88.8 (88.0 to 89.7) 19.0 (16.1 to 21.8) 99.3 (99.0 to 99.5)
Results of each period are indicated in percentages with confidence intervals at 95%
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Introduction: The optimal evaluation of fluid resuscitation in patients
with acute respiratory distress syndrome (ARDS) remains to be clearly
elucidated. The purpose of this study was to clarify the influence of fluid
overload in patients with ARDS.
Methods: Two hundred and seven ARDS patients admitted to the ICUs of
23 tertiary referral hospitals in Japan were enrolled in this study. These
patients were divided into survivor (survival group, n = 137) or
nonsurvivor (nonsurvival group, n = 70) groups according to the 28-day
mortality. All patients received mechanical ventilation and also underwent
transpulmonary thermodilution monitoring. The data for analysis were
collected for three consecutive days from time of admission.
Results: On the second hospital day, the extravascular lung water index of
the nonsurvival group was significantly higher than that of the survival
group (18.6 ± 9.4 ml/kg vs. 15.4 ± 6.3 ml/kg, P = 0.03). Moreover, regarding
the first 3-day cumulative fluid balance, the nonsurvival group was
significantly higher than survival group (5.1 ± 4.3 l vs. 3.5 ± 0.4 l, P = 0.015).
We suspected that these results might be related to the cardiovascular and/
or renal function. We therefore excluded any patients with a score of three
or more regarding the cardiovascular and/or renal criteria about
the Sequential Organ Failure Assessment score. Thereafter, we confirmed
the results to be similar for the first 3-day cumulative fluid balance between
the two groups (3.8 ± 1.6 l vs. 2.2 ± 4.0 l, P = 0.0339). A stepwise logistic
regression analysis identified the 3-day cumulative fluid balance to be an
independent risk factor for the 28-day mortality (adjusted odds ratio: 1.0001,
95% CI: 1.000017 to 1.000217, P = 0.0252).
Conclusion: Our findings suggest that excessive fluid resuscitation may
therefore have a negative impact on the 28-day mortality for patients
with ARDS.
Acknowledgements: In this study, we retrospectively analyzed the
database of a multicenter observational study (The PiCCO Pulmonary
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Introduction: Systemic infection of the human host can arise from several
pathogenic bacteria as well as from fungal species, and it is of high clinical
relevance to trace back the nature of infection from the host response.
Amongst these systemic infections are sepsis inducers Candida albicans and
Mycobacterium tuberculosis, responsible for a great amount of worldwide
deaths [1]. Sepsis, however, does not necessarily originate from infection.
Traumas and non-infection-based injuries can also trigger an unbound
inflammatory response from the human host most commonly known as
systemic inflammatory response syndrome. Both cases, infection and non-
infection, nevertheless display similar clinical symptoms with significantly
better recovery times of patients included in the latter. Despite the clinical
similarities, studies have suggested that distinct infection-induced host
responses from different pathogens occur, namely at the signalling pathway
level [2].
Methods: Studies have been performed focused on common gene
expression profiles between several pathogens [3]. However, understanding
the difference in immune responses between these two pathogens, but not
exclusively, might lead to better diagnostic tools and treatment decision-
making. Relying on systems biology concepts and bioinformatics tools, we
use gene expression data to distinguish C. albicans and M. tuberculosis
infections in the human host; for example, cellular regulation and
communication between host immune cells and pathogens [4,5].
Results: We have, in a first analysis, focused on the cytokine-cytokine
signalling pathway due to its role in inflammation response towards
infections. Genes belonging to the IL-2 cytokine family are only expressed
when facing infection by C. albicans in comparison to M. tuberculosis
suggesting a tendency towards B-cell proliferation and production of
antibodies. However, during infection caused by M. tuberculosis, no
significant changes in gene expression occur in this pathway that indicates a
specific immune response for this pathogen. Further analysis of additional
signalling pathways might highlight other human infection-specific immune
responses in regards to the pathogens considered.
Conclusion: Next we will focus on developing a mathematical model
capable of simulating such immune responses and possibly identifying
genes and pathways which might clarify how these inflammation
responses can be targeted, countered and moderated [6].
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Introduction: Systemic salmonella infection is a frequent cause of Gram-
negative sepsis. Bacterial lipopolysaccharide in blood triggers immune
response by monocytes, which results in overwhelming production of
proinflammatory cytokines and pathology in peripheral organs such as the
liver, heart and lungs. The mortality rate due to sepsis remains high even
after chemotherapeutic clearance of pathogens, due to sustained
production of inflammatory mediators. Therefore, anti-inflammatory therapy
as an adjunct to antibiotics could reduce the mortality from sepsis.
Methods: To date, several studies have evaluated the role of vasoactive
intestinal peptide (VIP) as a therapeutic agent in sepsis both in vivo and in
vitro since it possesses several desirable biological properties. The peptide,
acting via VIP cell receptors, mediates effects by altering production and
secretion of inflammatory mediators such as cytokines. VIP has been
shown to decrease production of proinflammatory cytokines, ameliorate
histopathological changes and inhibit mortality in mice rendered septic by
LPS administration. Nothing is known about the effect of VIP on
production of proinflammatory cytokines in human monocytes infected by
virulent Salmonella.
The aim of the current study, therefore, was to investigate the effect of
vasoactive intestinal peptide on the production of inflammatory cytokines
in human monocytes exposed to S. Typhimurium 4/74.
Results: Our finding demonstrates that freshly isolated human monocytes
produce proinflammatory cytokines such as TNFa, IL-6, IL-1b and also anti-
inflammatory cytokines such as IL-4 and IL-10 following bacterial challenge.
Conclusion: However, co-culture of infected monocytes with VIP (10-7 M)
significantly reduced (P < 0.05) production of TNFa, IL-6, IL-1b but significantly
increased (P < 0.05) concomitant production of anti-inflammatory IL-10.
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Introduction: The Integrated Nurse Leadership Program (INLP), a regional
quality improvement initiative to reduce deaths from sepsis, began in 2008.
Nine participating hospitals were provided networking opportunities and
training on: care of the septic patient, program and leadership development,
and data collection and analysis. El Camino Hospital (ECH) applied these
concepts during implementation of the early goal-directed therapy bundle
as recommended by the Surviving Sepsis Campaign and the Institute for
Healthcare Improvement. This paper describes the implementation process
and presents data analysis from the 22-month project, focusing on severe
sepsis and septic shock mortality.
Methods: A multidisciplinary team approach guided the sepsis initiative.
Lean methodologies such as: root cause analysis, process mapping, data
collection and direct observation were applied. Frequent meetings with
executive personnel, frontline staff and physician leaders occurred to
evaluate current practices. Policies and procedures were created, including
standardized screening tools and order sets for early identification and
management. Training materials (modules, lectures, handouts and
simulations) were developed. Extensive training occurred at all levels, with
experts presenting to large groups of clinicians. Ongoing data analysis
included screening tool and bundle element compliance as well as ICD-9-
based mortality among patients with severe sepsis and septic shock
(excluding patients <18 years old, pregnant, or designated ‘Do Not
Resuscitate’ within 24 hours of presentation). Length of stay (LOS) data
were compared with data from a large healthcare collaborate quality
alliance (Premier) using US Medicare Severity Diagnosis-Related Group
sepsis codes (MSDRG 870, 871, 872).
Results: Prior to implementation of the program (April 2009) through
April 2014, ECH achieved a relative reduction of 68% in the mortality rate
among those with severe sepsis and septic shock (P = 0.03). This equates
to 1,456 lives saved (Figure 1) [1-3]. During the initiative ECH maintained
a lower than expected average LOS compared to other hospitals within
the Premier database (Figure 2).
Conclusion: The significant and sustained decrease in mortality among
those with severe sepsis and septic shock was achieved through the
structure and support of multisite collaboration with the INLP and robust
internal operations [1,3]. The focus is now on sustainability; including key
elements pertaining to accountability, affordability, compassionate care
and systematic excellence [4].
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Figure 1(abstract P28) Mortality among patients with severe sepsis and septic shock; excluding patients <18 years of age, pregnant females
and patients designated ‘Do Not Resuscitate’ within 24 hours of presentation
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Introduction: In 2002 the international Surviving Sepsis Campaign was
initiated. Following this, Dutch authorities introduced a nationwide safety
campaign, encouraging screening for sepsis and advocating early treatment.
In 2010, the Albert Schweitzer hospital, a large community hospital,
introduced a screening program for sepsis in the emergency department
(ED) [1]. The goal of this study was to evaluate the bacterial outcome in
patients targeted with this campaign.
Methods: All patients 18 years and older visiting the ED were screened
using the criteria of systemic inflammatory response syndrome (SIRS).
Patients with more than two SIRS criteria and a clinical suspicion for
infection were eligible for prompt antibiotic administration, after a short
assessment by an ED physician. Patient data were collected prospectively,
but a retrospective analysis was conducted using a cohort of patients
presenting in the ED in the first 6 months of 2011. The definitions for sepsis
severity were derived from the guidelines of the Surviving Sepsis Campaign
in 2008 and criteria to define bacterial infection were derived from an article
by Limper and colleagues [2].
Results: A total of 269 patients were included in the study. Review of
infectious outcomes showed no evidence of bacterial disease in 79 (29.4%)
patients. Of these patients, 70.9% were in the lowest category of sepsis (SIRS
and clinical suspicion of infectious disease). Patients in the lowest category
were less likely to suffer from bacterial infection than patients (P = 0.046, see
Table 1). In the patients without objective bacterial infection, the median
duration of antibiotic treatment was 7 days (IQR 4 to 10). Overall mortality
was 7.8 %, which is low compared to current literature regarding (severe)
sepsis [3,4], but comparable to literature addressing SIRS and fever in the ED
settings [5-8].
Conclusion: Much effort has been put into promoting early antibiotic
treatment for (bacterial) sepsis. However, overtreatment has hardly been
addressed and no optimal screening strategy has been identified.
Evaluation of our screening protocol using SIRS criteria showed that almost
30% of patients did not suffer from bacterial infection but did receive
antibiotic treatment for a median duration of 7 days. Future investigations
should address the possible negative effects of overtreatment.
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Figure 2(abstract P28) Average length of stay for patients with sepsis codes (MSDRG 870, 871, 872), comparing El Camino Hospital to
expected LOS from the Premier database. Red line, Premier database expected LOS for sepsis patients; blue line, El Camino Hospital LOS for sepsis patients.
Table 1(abstract P29)
No bacterial infection (n = 79) Bacterial infection proven/probable (n = 190) P value
Culture-proven infection - 97 (51.1%) -
Positive blood cultures - 51 (26.8%) -
Probable bacterial infection - 93 (48.9 %) -
Sepsis category
Sepsis 56 (70,9%) 110 (57.9%) 0.046a,b
Severe sepsis 20 (26,3%) 57 (30.0%) 0.549a
Sepsis-induced hypotension 2 (2,6%) 18 (9.5%) 0.053a,b
Septic shock 1 (1,3%) 5 (2.6%) 0.506a
Antibiotic treatment duration (days)c 7 (4 to 10) 10 (7 to 14) 0.000b,d
aChi-square test. bTest reached statistical significance. cData provided as median (IQR). dMann-Whitney U test
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Introduction: Sepsis is the predominant cause of morbidity and mortality in
patients with peritonitis [1-6]. The Surviving Sepsis Campaign (SSC) is an
international effort in reducing mortality based on evidence-based guidelines
[7-13]. This study aims to assess the impact of audit-based feedback in a
Plan-Do-Study-Act (PDSA) format on improving implementation of the SSC
guidelines in patients with generalised peritonitis at our centre.
Methods: This prospective observational study was conducted in four audit
cycles in PDSA format. Multidepartmental inputs were taken to suggest
modifications in practice. A questionnaire-based analysis of reasons for
noncompliance was done to find out the opinions and reasons for
noncompliance. Morbidity, mortality, the ICU and hospital stay among these
patients were also analysed.
Results: The baseline compliance with i.v. bolus administration, CVP-
guided fluids and inotrope supports when indicated were 100%. Over the
course of the three audit cycles, statistically significant improvement in
compliance was noted for antibiotic administration within 3 hours of
presentation (46% to 90%) (Table 1 Figure 1), obtaining blood cultures
before antibiotics (13.8% to 72.5%) (Table 1 Figure 2) and serum lactate
measurement (0% to 78.2%) (Figure 3). Overall bundle compliance improved
from 9.2% to 64.7% (Table 2 Figure 4) by the end of Audit III. The mortality
rate decreased from 32.3% to 20% (Table 2 Figure 5).
Conclusion: This study demonstrates that audit-based feedback is a
dependable means of improving compliance with SSC guidelines. It brings
about improvement by educating users, by modifying their behaviour
through feedback and also enhances process improvement by identifying
and correcting systemic deficiencies in the organisation.
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Introduction: Surgical site infection (SSI) previously termed postoperative
wound infection is defined as that infection presenting up to 30 days after a
surgical procedure if no prosthetic is placed and up to 1 year if a prosthetic
is implanted in the patient. Several recommendations have been published
(skin preparation, surgical antibiotic prophylaxis, control of the OR
environment and improvements in the surgical technique) to improve the
patient safety and quality of care in the OR. Use of the bundle of care to
improve patient outcomes is becoming more widespread; however, their
use is more common internationally than in India.
Methods: A surveillance study for SSI after routine surgical procedures was
conducted from September 2012 until August 2014. A bundle of care
consisting of five elements covering the surgical process was introduced in
September 2013. The elements of the bundle were perioperative antibiotic
prophylaxis, hair removal before surgery, perioperative normothermia,
perioperative euglycemia and operating room discipline. Normothermia was
defined as a temperature between 36.0 and 38.0°C. Euglycemia was defined
as blood glucose <180 mg/dl. Antibiotic prophylaxis was given 15 minutes
before the incision. Hair removal whenever needed was done with clippers.
Theatre discipline was counted for following points: permanent wearing of
scrub suits, surgical cap and mask covering the nose and mouth by all
persons in the OR during the surgical procedure. The incidence of SSI was
studied as a primary outcome. Morbidity/mortality for next 3 months was
studied as the secondary outcome.
Results: Implementing the bundle of care led to a decline in infection
rate from 15% before the intervention to 11.4% after the introduction of
bundle of care, a fall of 27%, which is significant (P < 0.001). No significant
difference in 3-month mortality was found. The compliance to this bundle of
care also steadily increased from 10% in September 2013 to 55% in August
Table 1(abstract P30) Compliance with obtaining blood cultures before antibiotics and antibiotic administration
within 3 hours
Number of patients Pre audit (n = 65) Audit I (n = 55) Audit II (n = 50) Audit III (n = 51)
Blood cultures obtained before antibiotics 9 (13.6%) 18 (32.7%)a 30 (60%)b 37 (72.54%)b
Antibiotics given within 3 hours 30 (46.1%) 30 (67.2%)c 40 (80%)d 46 (90.1%)b
aP = 0.016. bP < 0.0001. cP = 0.463. dP = 0.0002
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Figure 1(abstract P30) Compliance with antibiotic administration within 3 hours of presentation
Figure 2(abstract P30) Compliance with obtaining blood cultures before antibiotic administration
Figure 3(abstract P30) Compliance with measurement of serum lactate
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Table 2(abstract P30) Total bundle compliance
Total number of bundle components performed Pre audit (n = 65) Audit I (n = 55) Audit II (n = 50) Audit III (n = 51)
6 0 0 0 33a (64.7)
5 6 (9.2%) 13 (23.6%) 27 (54%) 3 (5.8%)
4 26 (40%) 29 (52.7%) 16 (32%) 11 (21.5%)
3 33 (50.7%) 13 (23.6%) 7 (14%) 4 (7.8%)
2 0 0 0 0
1 0 0 0 0
aSerum lactate was available in the hospital only during audit cycle III
Figure 4(abstract P30) Overall bundle compliance
Figure 5(abstract P30)
Table 3(abstract P30) Overall mortality
Pre audit (n = 65) Audit I (n = 55) Audit II (n = 50) Audit III (n = 51)
Overall mortality in percentage 21 (32.3%) 16 (29%) 12 (24%) 11 (20%)
P value (compared with the initial cycle) 0.843 0.407 0.143
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2014. For 542 surgical procedures during the study period, 62 SSI (11.4%)
occurred as compared to 102 cases for 680 in the control period (15%). The
adjusted odds ratio of the SSI rate was 0.7319 and was found to be 27%
lower post intervention.
Conclusion: The implementation of the bundle was associated with
improved compliance over time and a significant reduction of the SSI
rate. This makes the bundle an important tool to improve patient
safety.
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Introduction: Direct hemoperfusion with polymyxin-B has been reported to
improve hemodynamics in postsurgical patients. In 2012, the Japanese
Guidelines for the Management of Sepsis were published and mention the
efficacy of polymyxin-B direct hemoperfusion. But how to use and the target
patients are varied by facilities. We investigated the effective use of
polymyxin-B direct hemoperfusion in nonsurgical patients.
Methods: We analyzed retrospectively all septic shock patients who were
treated with polymyxin-B hemoperfusion between January 2008 and
December 2012.We checked their mean arterial pressure (MAP), and
vasopressor requirement every 30 minutes until stopping treatment.
Results: There were 32 patients under treatment and 11 patients did not
need surgical treatment. Even in the nonsurgical group, hemodynamic
states and vasopressor requirement was improved after polymyxin-B
hemoperfusion started. And the effects were continued over 120 minutes. A
second plolymyxin-B hemoperfusion treatment underwent in nine patients.
In second treatment, MAP increased in the nonsurgical group greater than
in the postsurgical group.
Conclusion: Polymyxyn-B direct hemoperfusion improves hemodynamic
status even in nonsurgical patients. A second polymyxin-B direct
hemoperfusion is effective especially in nonsurgical septic shock patients.
And if its hemodynamic effect was significantly, long-time treatment
should be considered.
P33
Sepsis modulates the human hematopoietic stem cell compartment in
peripheral blood and bone marrow.
T Skirecki1,2*, U Zielińska-Borkowska2, J Kawiak1, G Hoser1
1Laboratory of Flow Cytometry, The Center of Postgraduate Medical
Education, Warsaw, Poland; 2Department of Anesthesiology and Intensive
Care, The Center of Postgraduate Medical Education, Warsaw, Poland
Critical Care 2014, 18(Suppl 2):P33; doi:10.1186/cc14036
Introduction: Efficient fight with infection requires robust production of
immunocompetent cells. This response is called emergency hematopoiesis
and depends on the proliferation of progenitor cells and awakening
dormant hematopoietic stem cells (HSCs) into cycling. As during sepsis
an altered immune system is often observed, it seems important to
reveal the impact of this syndrome on HSCs. Recent discoveries have
shown that HSCs circulate in the peripheral blood and may boost local
immune response via paracrine mechanisms and differentiation into
myeloid cells. Altogether, these rationales led us to investigate the
circulating HSCs in septic patients and in the bone marrow (BM) of septic
‘humanized mice’ transplanted earlier with human HSCs.
Methods: Samples of peripheral blood were collected from 23 patients with
sepsis (on days 1 and 3) and 20 healthy volunteers. The following antigens
were analyzed by flow cytometry: CD34, CD38, Ki-67, CD133, Lin and CD45.
In order to investigate HSCs in their microenvironment, a model of cecum
ligation and puncture (CLP) was performed on the NOD.Cg-Prkdc/scidIL2rg
mice that were transplanted with human cord blood CD34+ cells 8 weeks
earlier. BM cells were analyzed 24 hours after CLP by colony-forming unit
assay with medium supporting growth of human cells.
Results: Septic patients had a significantly increased (threefold, P < 0.01)
number of CD34+CD38- HSCs on the third day of the disease. Also, the
CD133+ HSC number was increased in septic patients, while CD34+CD45
+Lin- progenitors were detected at much lower level than in controls.
Interestingly, Ki-67+CD34+Lin- cells were fourfold higher in septic patients.
Patients with higher number of CD133+ HSCs had significantly lower
likelihood of 60-day survival (P < 0.05). Analysis of human HSCs from BM
of septic mice revealed significantly compromised hematopoietic colonies
output (248 vs. 125 in sham animals). CLP caused also expansion of
CD34+CD38- HSCs in BM and absolute increase of Ki-67+CD34+Lin- cells
(1.5-fold).
Conclusion: In this work we have observed significant changes in
circulating HSCs during sepsis. During the disease, dormant HSCs enter the
cell cycle (measured by Ki-67 expression) and are mobilized to the
peripheral blood. However, the progenitor cells disappear from circulation.
Novel use of humanized mice confirmed expansion of early human HSCs in
BM during the sepsis model. Despite expansion of the HSC pool, the
amount of functional progenitors in BM is decreased in this model. We
suggest that HSCs play a significant role in the course of sepsis and may
become a new prognostic and therapeutic target.
Acknowledgements: Supported by ‘Innovative Methods of Stem Cell
Applications in Medicine’, EU Innovative Economy Operational Program,
POIG 01.02-00-109/09.
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Introduction: Fluid bolus therapy (FBT) is a ubiquitous intervention in
intensive care. However, the physiological effects in the critically ill are
poorly understood. Therefore, we systematically reviewed the contemporary
literature to determine the current practice and effect of FBT in the
management of severe sepsis and septic shock.
Methods: We interrogated the MEDLINE, CENTRAL and EMBASE electronic
reference databases using a combination of terms to define a set of records
of studies of fluid administration in patients with severe sepsis or septic
shock. To achieve contemporary relevance, results were limited to English-
language studies in adults between 2010 and 2013.
Results: We identified 22 prospective observational studies, four
retrospective observational studies, two quasi-experimental studies, and five
randomised controlled trials (RCTs), 41 boluses in total. No RCT compared
FBT with alternative interventions. The median fluid bolus was 500 ml
(range: 100 to 1,000 ml) administered over 30 minutes (range: 10 to
60 minutes) and 0.9% sodium chloride solution was the most commonly
administered. Although 17 studies describe the temporal course of
physiological changes after FBT in 31 patient groups, only three studies
describe the physiological changes at 60 minutes, and only one study
beyond this point (Figure 1). No studies related the physiological changes
after FBT with clinically relevant outcomes.
Conclusion: There is a need for obtaining randomised controlled evidence
for the physiological effects of FBT in patients with severe sepsis and septic
shock beyond the period immediately following its administration.
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Introduction: Patients are frequently rehospitalized in the 90 days after
severe sepsis. The rate of readmission exceeds patients’ baseline rate of
hospitalization, and also exceeds the rate after matched nonsepsis
hospitalizations [1]. We sought to determine the most common readmission
diagnoses after severe sepsis, the extent to which readmissions may be
preventable, and whether the pattern of readmission diagnoses differs from
that of nonsepsis hospitalizations.
Methods: We studied participants in the US Health and Retirement Study
with linked Medicare claims (1998 to 2010) [2]. Using validated methods
[3,4], we identified severe sepsis and nonsepsis hospitalizations, then
measured 90-day readmissions in each cohort. Using Healthcare Cost &
Utilization Project’s Clinical Classification Software [5], we determined the
10 most common readmission diagnoses after severe sepsis. We measured
rates of ‘potentially preventable’ readmissions using published definitions
[6]. We compared rates of all-cause, potentially preventable, and cause-
specific hospitalizations between survivors of severe sepsis and nonsepsis
hospitalizations using chi-squared tests.
Results: We identified 3,703 severe sepsis and 44,840 nonsepsis
hospitalizations, of which 3,036 (82.0%) and 43,539 (93.1%) survived to
discharge, respectively. In the next 90 days, 43.6% of severe sepsis
survivors were rehospitalized, compared to 34.8% of nonsepsis survivors,
P < 0.001. The top readmission diagnoses following severe sepsis (Table 1)
included several recognized potentially preventable diagnoses: heart
failure, pneumonia, exacerbation of chronic obstructive pulmonary disease
(COPD), and urinary infection. Also common were readmissions for sepsis,
acute renal failure, and aspiration pneumonitis, diagnoses that could
plausibly be prevented or treated early to prevent hospitalization. Patterns
of readmission differed in severe sepsis survivors; rates of readmission for
sepsis, renal failure, respiratory failure, device complication, and aspiration
pneumonitis were higher and accounted for a greater proportion of the
total readmissions. Potentially preventable hospitalizations - infection
(sepsis, pneumonia, urinary tract, and skin or soft tissue), heart failure,
COPD exacerbation, acute renal failure, and aspiration pneumonitis -
accounted for 40.5% of all readmissions after severe sepsis (compared to
25.8% following nonsepsis admission, P < 0.001), and 19.6% of severe
sepsis survivors experienced a readmission for one of these diagnoses
(compared to 9.5% following a nonsepsis admission, P < 0.001).
Conclusion: Forty percent of hospitalizations after severe sepsis occur for
diagnoses that may be preventable. A few disease categories account for
a relatively large proportion of the hospitalizations after severe sepsis,
suggesting the feasibility of tailoring postdischarge interventions to
patient’s personalized risk for these common postsepsis diagnoses.
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Figure 1(abstract P34) Haemodynamic changes following FBT at 1, 2, 3 and 4 hours
Table 1(abstract P35) Top ten hospitalization diagnoses in the 90 days following severe sepsis
Rank Diagnosis category Proportion of all 90-day admissions (%) Survivors with 90-day admission (%)
1 Congestive heart failure, nonhypertensive 10.4 5.7*
2 Septicemia 9.5* 6.5*
3 Pneumonia 5.4 3.5*
4 Rehabilitation care 5.1 3.2
5 Acute and unspecified renal failure 4.6* 3.2*
6 Respiratory failure 4.1* 2.5*
7 Complication of device, implant, or graft 3.5* 2.3*
8 COPD and bronchiectasis 3.1 1.8
9 Urinary tract infection 3.1 1.8*
10 Aspiration pneumonitis 2.8* 1.8*
*Value greater than that of nonsepsis survivors, P ≤ 0.001 for each comparison
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Introduction: Sepsis is a systemic inflammatory response resulting from the
inability of the host to restrict the infection locally. Studies realized in our
laboratory demonstrated that the high mortality observed in severe sepsis
(S-CLP) correlates with the failure of the neutrophil migration to infectious
focus and infection dissemination. However, animals subjected to a model
of local infection (NS-CLP) present an efficient neutrophil recruitment that
constrains the spreading of infection. In this context, we demonstrated a
direct action of IL-17 mediating the neutrophil recruitment [1]. Recently, it
was demonstrated that aryl hydrocarbon receptor (AhR) activation has a role
in immune response. The AhR is expressed by Th17 cells and also by innate
immune system cells and is important for their effectors functions, including
IL-17 and IL-22 production [2]. However, the function of the AhR in sepsis
remains uncertain. Herein, we investigate the role of AhR in polymicrobial
sepsis induced by cecal ligation and puncture (CLP).
Methods: C57BL/6 mice were subjected to NS-CLP or S-CLP sepsis. The
protein expressions of AhR, CYP1A1 (indicator of AhR activation) and AhRR
(AhR repressor) were determined in the spleen, liver and lung by western
blot, 18 hours after sepsis. AhR and CYP1A1 were also evaluated, 6 hours
after surgery, by RT-PCR in peripheral blood mononuclear cells (PBMC). Mice
were pretreated subcutaneously with 30 μg/kg FICZ, high-affinity AhR
agonist, 12 hours and 1 hour before the induction of moderate sepsis
(M-CLP). Intraperitoneal neutrophil migration, bacteremia, kidney function
and AhR activation were determined 6 hours after surgery. The survival rate
was assessed every 12 hours up to 120 hours.
Results: We observed reduced expression of AhR, CYP1A1 and increased
AhRR expression in all analyzed organs of the S-CLP group compared with
the NS-CLP group. Moreover, AhR and CYP1A1 were not detected in PBMC
after S-CLP. Our results also demonstrated that activation of Ahr, through
FICZ pretreatment, increased the neutrophil recruitment to the peritoneal
cavity of mice subjected to M-CLP. Consequently, these animals presented
reduced bacteremia and kidney injury, resulting in increased survival rate.
Conclusion: These data suggest that during severe infection the AhR
expression and activity is reduced and can contribute to the mortality
observed in this process.
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Introduction: Enterococcal bacteraemias are associated with high
mortality rates, ranging from 23 to 48% in critically ill patients. However, it
remains uncertain whether these events are causes or merely markers of
disease severity and mortality. Our aim was to describe the epidemiology,
management and clinical outcomes of ICU-acquired enterococcal
bacteraemia in comparison to other frequently isolated pathogens.
Furthermore, we aimed to estimate the population attributable fraction of
ICU mortality caused by enterococcal bacteraemia.
Methods: Between January 2011 and March 2013 we included consecutive
patients with an ICU length of stay of at least 3 days in two tertiary care
centres in the Netherlands. ICU-acquired bacteraemia was defined as a first
positive blood culture occurring at least 3 days after ICU admission.
Enterococcal bacteraemias were compared to other frequently isolated
pathogens with respect to patient characteristics, their management and
outcomes. We used competing risk survival regression, a multistate model
and cumulative incidence functions to estimate the population attributable
fraction of ICU mortality due to enterococcal bacteraemia.
Results: Out of a total of 3,108 patients, 222 (7.1%) patients were responsible
for 272 events of ICU-acquired bacteraemia, of which 76 were due to
enterococci, 124 to coagulase-negative staphylococci and 40 to Gram-
negative bacteria. Patients with enterococcal bacteraemia were more severely
ill compared to patients with bacteraemia caused by other pathogens. In
comparison to patients with coagulase-negative staphylococci, those with
enterococci were more frequently managed with renal replacement therapy
and also had more intravascular or orthopaedic hardware. Although crude
ICU mortality was higher in patients with bacteraemias due to enterococci
compared to coagulase-negative staphylococci, this association disappeared
after adjustment for confounders (subdistribution hazard ratio 1.04, 95%
confidence interval 0.65 to 1.68). The population attributable fraction of ICU
mortality due to enterococcal bacteraemia was 4.7%.
Conclusion: Bacteraemias with enterococci occur in more severely ill
patients, but their virulence seems comparable to that of coagulase-
negative staphylococci. Furthermore, the population attributable fraction
of ICU mortality due to enterococcal bacteraemia is low. Therefore,
enterococcal bacteraemias are more likely to be markers than causes of
increased disease severity and mortality.
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Introduction: Systemic inflammatory response syndrome (SIRS) was
defined in pediatrics primarily to aid in research subject identification. There
is a paucity of data on the clinical utility of SIRS in the pediatric population.
We aimed to determine the incidence of SIRS in children presenting to the
pediatric emergency department (PED) of a mid-sized Canadian tertiary care
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center and, secondarily, to examine the sensitivity and specificity of SIRS for
predicting infection, the range of clinical entities presenting with SIRS, and
outcomes of children with SIRS.
Methods: We conducted a prospective cohort study of all children from
birth to 18 years presenting to the PED on 16 days distributed evenly over
1 year. Charts of all patients presenting to the PED on study days were
reviewed to determine the presence of SIRS and sepsis. Three pediatricians
adjudicated all cases of presumed infection. All patients were followed for
1 week to determine outcomes.
Results: The incidence of SIRS was 14.3% (n = 202 of 1,416). The rate of
documented or presumed infection in the entire population was 37.1% (n =
525), and in SIRS patients was 81.2% (n = 164). Therefore, 11.6% of the
population (n = 164) met criteria for sepsis, one patient had severe sepsis,
and there were no cases of septic shock. Sensitivity and specificity of SIRS
for predicting infection was 31.2% (95% CI: 27.3 to 35.4%) and 95.7% (95%
CI: 94.2 to 97.0%) respectively. No difference in sensitivity or specificity was
seen when cases were separated by age. Patients with SIRS had a higher risk
of requiring hospital admission with a relative risk of 2.8 (95% CI: 2.0 to 4.1,
P < 0.0001). Although children with SIRS stayed in hospital statistically
longer (P < 0.001), the median length of stay for both groups was ≤1 day.
However, 28.7% (n = 47) of patients meeting definition of sepsis had
nonsevere infection types (for example, acute otitis media, viral upper
respiratory tract infection); 72.3% of patients with SIRS and 75% of patients
meeting sepsis criteria were discharged home from the PED without return
visits.
Conclusion: While SIRS has a high specificity for infection, its poor
sensitivity suggests a risk of missing infection if used as a screening tool.
Although patients with SIRS have an increased risk of admission, the current
definition of sepsis may result in over-inclusion of patients with nonsevere
disease.
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Introduction: Pneumonia is the major cause of sepsis, responsible for
almost one-half of all sources of infection [1]. Sepsis and septic shock lead to
organ failure and death. Spreading of microorganisms and their toxins
through the blood could contribute to the organ dysfunction. The heart,
liver and kidney are examples of organs damaged during the systemic
infection and organ failure predicts poor prognosis in patients with sepsis
[2]. However the correlation, if any, between bacterial spreading and organ
injury is unclear. Thus, the aim of this study was to study the bacterial
systemic spreading from a localized infection along with time and the target
organ inflammatory profile using proinflammatory cytokines as surrogate
markers.
Methods: Pneumosepsis was induced by Klebsiella pneumoniae as
described in [3]. The number of viable bacteria inoculated was 109 colony-
forming units to achieve a mortality rate of ~50% by 48 hours. Blood, lung,
heart, liver, spleen, kidney and brain were aseptically harvested,
homogenized and plated on Müeller-Hinton agar dishes, for 18 hours at
37°C. Plasma and the tissues homogenates were assayed for interleukin-6
(IL-6) and interleukin-1b (IL-1b) using commercially available enzyme-
linked immunosorbent assay kits according to the manufacturer ’s
recommendations (PeproTech Inc., Rocky Hills, NJ, USA).
Results: Lung inoculation with K. pneumoniae evolved to systemic
spreading of bacteria to all organs, mostly the liver and kidney. Surprisingly,
bacteria were found as early as 30 minutes in vital organs such as the brain
and heart. The infection in the organs rose steadily up to 24 to 48 hours.
Significant increases in IL-6 and IL-1b were found in the plasma, 24 hours
after infection. However, cytokine levels in the organs were as high as
fivefold the plasma levels.
Conclusion: Our data show that the early bacterial dissemination may be
important for the onset of organ inflammation. Assuming that the higher
organ cytokine level is a marker of an ongoing inflammation, this may
explain organ dysfunction during sepsis. Thus, our study suggests that
systemic (meaning blood) parameters may not reflect the severity of
inflammation/dysfunction in target organs, and that might be the
determinant to sepsis outcome.
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Introduction: Sepsis remains a leading cause of mortality in our ICUs. Ileus,
defined as the inhibition of the propulsive motility in the gastrointestinal (GI)
tract, together with mucosal barrier dysfunction will maintain sepsis by the
translocation of intestinal bacteria. Preliminary data in our group showed
that the administration of GTS-21, a selective alpha7 nicotinic acetylcholine
receptor (a7nAChR) agonist, ameliorates inflammation and GI motility
disturbances during sepsis [1]. Activation of the a7nAChR is the final step in
the vagal anti-inflammatory pathway, a spleen-dependent and macrophage-
dependent pathway that dampens inflammation. We aimed to study the
effects of splenectomy (SPLX) combined with GTS-21 on GI motility and on
local colonic and systemic inflammation, as the role of the spleen in the
vagal anti-inflammatory pathway is currently under debate.
Methods: Septic ileus was induced in Swiss-OF 1 mice by cecal ligation and
puncture (CLP). One week prior to CLP, mice underwent SPLX or sham
surgical incision (sham). GTS-21 (8 mg/kg) or vehicle was administered
intraperitoneally 1 hour before CLP, and once every 24 hours after the
procedure. Mice were sacrificed 48 hours following CLP. Motility was
assessed by measurement of GI transit of beads, with calculation of
percentage of gastric emptying (%GE) and geometric center (GC). Serum
samples were analyzed with cytometric bead array (CBA) for the
proinflammatory cytokines IL-6 and TNFa. Supernatants of centrifuged
homogenized colonic samples were assessed with CBA for IL-6 and TNFa
Results: Administration of GTS-21 resulted in a significant improvement
in GI motility in septic mice, as was demonstrated by an increase in the
%GE and GC (Table 1). GTS-21 significantly decreased the serum
concentration of IL-6, but not TNFa, in septic mice treated with GTS-21
compared to vehicle-treated mice. Prior SPLX protected mice from
developing ileus following CLP. SPLX + vehicle mice demonstrated a
significantly lower serum concentration of IL-6 and TNFa compared to
sham + vehicle, and colonic TNFa levels declined significantly following
SPLX. Administering GTS-21 in SPLX mice did not result in an additional
benefit on GI motility, nor on systemic or local colonic inflammation
(Table 1).
Conclusion: Splenectomy protects mice from developing ileus following
CLP, an animal model of polymicrobial sepsis, as does the preventive
administration of the selective a7nAChR agonist GTS-21. Splenectomy
resulted in a reduction of systemic TNFa and IL-6 levels, indicating that the
spleen is a major source of proinflammatory cytokines. GTS-21 ameliorates
CLP-induced septic ileus, but did not lead to a complimentary benefit in
addition to splenectomy.
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Introduction: Biomarker discovery research has not focused on the
emergency department (ED) due to perceived lack of access to ED patients
for study, difficult patient identification, and preemption by time-critical
clinical needs. The aim of this study was to use an automated process to
accrue, within the ED, a biobank of patients presenting at risk for severe
sepsis.
Methods: Our group has previously derived an algorithm for identification
of at-risk patients of which about 45% will be severely septic [1]. Here, we
utilize that algorithm to identify a prospective cohort to be included in our
ED sepsis biobank. Patients are excluded if they are pregnant, <18 years
old, a vulnerable adult, or imprisoned. An electronic notification system
identifies patients and automatically pages phlebotomy and laboratory
processing personnel directly. Blood draws occur immediately after patient
identification and at 6 and 24 hours into hospitalization. We use an IRB-
approved delayed consent model that minimizes the time between
identification and blood draw. Plasma extracts and cellular isolates are
processed and stored immediately. Clinical data are extracted for relevant
patient outcomes, severe sepsis, and indicators of critical illness.
Results: In 1 year of accrual, the alert algorithm identified 1,773 eligible
patients for screening. Blood was drawn from 873 patients based on
phlebotomy availability and laboratory processing staffing. A total of 642
patients completed blood draws and consented for inclusion, with the
balance of patients having been discharged, transferred, or deceased with
no identifiable legally authorized representative for consent. The median
time from alert to first blood draw was 25 minutes (range 5 to 60 minutes).
In an observation period, during which 227 consecutive patients had blood
drawn, only 12 patients or families (5.2%) declined consent after the initial
blood draw.
Conclusion: We have successfully developed and implemented a biobank
in the ED that functions within practice limitations and has high patient
accrual. Automation is key for efficient implementation in the ED. Using
automated design improvements, we obtain blood samples from sepsis
patients presenting to the ED faster than previous studies. Prompt biobank
collection within the ED allows research into mechanisms of sepsis earlier
in a patient’s hospital course than has heretofore been possible and
enables biomarker discovery for testing development directly relevant to
emergency providers.
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Introduction: Fever predicts an infection cause of SIRS/sepsis more
specifically than other commonly used hemodynamic criteria. Traditionally, a
body temperature of 38.0°C has been used to define fever, but this cutoff is
based on limited research. Furthermore, it has been proposed that fever
responses are blunted in older adults, limiting the utility of fever in infection.
This study determines the likelihood that a body temperature will predict
diagnosis of infection in the emergency department (ED).
Methods: This was a retrospective cohort analysis of adult patients (>18
years old) presenting to a large academic emergency department from
September 2010 to December 2012. Patient age, emergency physician
diagnosis, final disposition, and initial body temperature were examined
for each patient. Likelihood of a diagnosis of infection was calculated for
all temperature ranges. Sensitivity and specificity of fever thresholds for a
Table 1(abstract P40) %GE, GC, serum cytokine levels (pg/ml) and colonic cytokine levels (pg/g colon) in mice that
underwent splenectomy or sham surgery, followed by the CLP procedure and administration of vehicle or 8 mg/kg
GTS-21
GI transit study (n = 11) %GE GC
Nonseptic animals 88.96 ± 8.13 4.86 ± 0.45
Sham + vehicle + CLP 53.27 ± 10.32 2.53 ± 0.42
Sham + GTS-21 8 mg/kg + CLP 83.62 ± 5.91* 4.26 ± 0.35*
SPLX + vehicle + CLP 79.49 ± 8.98* 3.86 ± 0.44*
SPLX + GTS-21 8 mg/kg + CLP 77.64 ± 11.81* 3.55 ± 0.52
Cytokine level in serum (n = 8 to 11) IL-6 TNFa
Nonseptic animals 2.57 ± 0.48 4.95 ± 0.29
Sham + vehicle + CLP 243.56 ± 54.89 63.72 ± 21.25
Sham + GTS-21 8 mg/kg + CLP 90.26 ± 31.31* 54.23 ± 25.14
SPLX + vehicle + CLP 74.31 ± 17.45* 11.52 ± 1.99#
SPLX + GTS-21 8 mg/kg + CLP 64.98 ± 7.15* 12.81 ± 3.91#
Cytokine levels in colonic tissue (n = 5 to 11) IL-6 TNFa
Nonseptic animals 20.43 ± 4.87 41.30 ± 4.47
Sham + vehicle + CLP 1281.85 ± 932.10 137.15 ± 61.36
Sham + GTS-21 8 mg/kg + CLP 134.88 ± 36.15 46.46 ± 5.03*
SPLX + vehicle + CLP 214.22 ± 75.88 29.97 ± 8.60*
SPLX + GTS-21 8 mg/kg + CLP 487.49 ± 343.87 46.03 ± 17.22*
Data presented as mean ± SEM. Two-way ANOVA or one-way ANOVA as appropriate with SNK post hoc testing; *P ≤ 0.05 versus sham + vehicle, #P ≤ 0.05
significant effect of splenectomy (SPLX)
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diagnosis of infection were calculated and receiver operating characteristic
(ROC) curves were generated. Confidence intervals were determined using
Newcombe-Wilson hybrid scoring with continuity correction.
Results: We identified and analyzed records from 121,587 patients,
including 37,933 persons >65 years old. Overall, 15.9% of patients received a
diagnosis of infection in the ED with those >65 years old having a higher
rate of infection at 18.3%. Likelihood of infection varied by temperature in a
nonlinear relationship (see Figure 1). In adults of all ages, temperature
>38.0°C had a specificity >99% for a diagnosis of infection in the ED
although sensitivity was relatively poor. Specificity decreases only slightly
with lower fever cutoffs (37.2 to 37.9°C) while sensitivity is increased to a
greater degree (see Table 1).
Conclusion: The likelihood of a diagnosis of infection increases at the
extremes of body temperature and is higher overall among older adults
(≥65 years old). In our population, elevated temperature was at least as
sensitive for a diagnosis of infection in older people as in younger adults.
The use of body temperature for predicting diagnosis of infection has an
overall low sensitivity but high specificity. Changing the current practical
definition of fever from ≥38.0°C to ≥37.5°C significantly increases sensitivity
of predicting infection without greatly impacting the specificity. Only 2.3%
of all patients had a temperature between 37.5 and 37.9°C, and these
patients were four times more likely to have a diagnosis of infection than
those with temperature of 36.0 to 36.9°C.
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Introduction: Sepsis is a life-threatening systemic inflammatory syndrome
(SIRS), which affects many organ systems, that leads to hemodynamic
changes in the presence of suspected or proven infection, advancing to
organ dysfunction and failure [1-3]. In recent studies, 377 out of 100,000
cases of sepsis were observed while $14,600,000,000 has been determined
as the average annual hospital costs. Although there are many studies, the
molecular mechanism is not yet clearly elucidated [2,3]. Lipopolysaccharide
(LPS) is the lipid molecule which the outer membrane of Gram-negative
bacteria used in designing the experimental sepsis model [4]. Ghrelin was
discovered in 1999 as a specific ligand for growth hormone secretagogue
receptor and then pleiotropic effects such as anti-inflammatory, antioxidant,
and so forth were found. Ghrelin was released in many tissues and organs in
which there also was its receptor. The liver is an organ which has ghrelin
receptors and was affected by sepsis primary [5,6].
Methods: In our study, male Wistar albino rats of average body mass 200 to
250 g were separated into four groups including: Control (n = 10), LPS (E. coli
055:B5, 5 mg/kg, n = 10), ghrelin (10 nmol/kg i.v., n = 10), LPS + ghrelin LPS
Figure 1(abstract P42) Likelihood of infection diagnosis as a function of initial body temperature
Table 1(abstract P42) Sensitivity and specificity of body temperature for a diagnosis of infection
18 to 64 years of age ≥65 years of age
Sensitivity (95% CI) Specificity (95% CI) Sensitivity (95% CI) Specificity (95% CI)
≥37.0 33.5% (32.6 to 34.3) 81.9% (81.6 to 82.2) 33.3% (32.2 to 34.4) 85.7% (85.3 to 86.1)
≥37.1 25.8% (25.0 to 26.6) 89.4% (89.1 to 89.6) 27.9% (26.8 to 29.0) 91.2% (90.8 to 91.5)
≥37.2 20.4% (19.7 to 21.2) 93.4% (93.2 to 93.5) 23.4% (22.4 to 24.4) 94.0% (93.7 to 94.3)
≥37.3 17.1% (16.4 to 17.8) 95.6% (95.5 to 95.8) 20.3% (19.3 to 21.2) 95.7% (95.5 to 95.9)
≥37.4 14.6% (14.0 to 15.3) 96.9% (96.8 to 97.0) 17.8% (16.9 to 18.7) 96.6% (96.4 to 96.8)
≥37.5 12.6% (12.0 to 13.2) 97.8% (97.7 to 97.9) 15.9% (15.0 to 16.7) 97.4% (97.2 to 97.6)
≥38.0 6.48% (6.06 to 6.93) 99.3% (99.2 to 99.3) 8.77% (8.12 to 9.47) 99.0% (98.9 to 99.1)
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(5 mg/kg, ghrelin 10 nmol/kg i.v., n = 10). Rats were decapitated 24 hours
after first injection. We aimed in this study to investigate effects of ghrelin in
sepsis which is created by LPS with sepsis descriptive parameters such as
body temperature and leukocyte count with proinflammatory cytokine TNFa
and anti-inflammatory cytokines IL-10 by ELISA, and hematoxylin and eosin
stain for observed morphological changes.
Results: We detected the increase of leukocyte number, hypothermia,
proinflammatory and anti-inflammatory cytokines such as TNFa and IL-10 as
developing inflammatory reactions, resulting in hemodynamic and
metabolic changes in rats treated with LPS. Also in groups with ghrelin
treatment, ghrelin affects leukocyte numbers, body temperature,
proinflammatory and anti-inflammatory cytokine levels and histological
changes in controls and the LPS group (Figures 1 to 4). As a result of
histologic examination, the curative effect of ghrelin partially on liver tissue
damage is observed (Figure 5).
Conclusion: We think the results of ghrelin may be affected depending on
the dose and duration. Also partial healing effects of ghrelin in our results
on this topic at the molecular level will contribute to other studies.
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Introduction: Acute viral (RSV and non-RSV) pneumonia is one of the most
common causes of lower respiratory tract infection in infants and children.
Although only 2 to 3% of infants with bronchiolitis require hospitalized
management based on published literature, in recent years we see more
children requiring hospitalization in high-dependency units. Most of these
children require intravenous fluid therapy and some form of oxygen
supplementation. As there is no standardized evidence-based parenteral
fluid therapy protocol specific for acute severe viral pneumonia available, we
decided to retrospectively analyze the result of our restrictive fluid therapy
protocol.
Methods: All children less than 5 years age admitted to our PICU from June
2013 to December 2013 with etiological evaluation confirmed acute severe
viral (RSV and non-RSV) pneumonia who received a minimum 48 hours of
parenteral fluid therapy were enrolled and the data retrieved from the case
sheet. The data analyzed were duration of PICU stay, hospital stay, oxygen
therapy requirement, duration of oxygen therapy and their relationship to
fluid balance on restrictive fluid regimen.
Results: A total of 32 children met the criteria for inclusion in the study
period, 23 boys (71.9%) and nine girls (28.1%). The median age of children
was 9.5 months (IQR 3.3 to 27.3). Of 32 children, 4/32 (12.5%) required
invasive mechanical ventilation; 5/32 (15.6%) required NP-CPAP; 12/32
(37.5%) were on HHFNC; and nasal prong oxygen supplementation in 26
(81.3%) children. The median duration of ICU stay was 68.9 hours (IQR 39.2
to 80.2), that of hospital stay was 116.5 (IQR 92 to 179.2). Fluid balance at
the end of 72 hours of ICU stay did not significantly differ the need for
ventilation (P = 0.45) or the duration of ventilation (P = 0.60). Fluid balance
in the first 72 hours correlated positively with change in serum sodium
Figure 5(abstract P43)
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levels indicating a fall in sodium levels with more positive fluid balance
(Spearman coefficient of 0.452 (P = 0.16)). There was no significant
correlation between fluid balance and duration of PICU/hospital stay (P =
0.58/0.75). eGFR calculated using modified Schwartz formula did not
correlate with treatment parameters like duration of ICU/hospital stay,
mechanical ventilation, and CPAP.
Conclusion: Positive fluid balance may not influence the duration of PICU
stay, hospital stay, or oxygen therapy in children with severe viral
pneumonia when initiated on restrictive (70% of Holliday Segar
calculation) parenteral fluid therapy. eGFR at admission did not influence
the fluid balance when they were uniformly initiated on restrictive
parenteral fluids. Further studies with calculated sample size may help to
confirm the observations.
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Introduction: Blood sugar control for patients with sepsis remains
controversial. We aimed to test the hypothesis that the variation of blood
sugar level is associated with patient outcome in this study.
Methods: A retrospective cohort study on nontraumatic adult patients
who visited the ED of a tertiary hospital in 2010 and had a clinical
diagnosis of severe sepsis was conducted. Patients with two sets of blood
culture ordered by emergency physicians and at least two blood sugar
tests results available during the first 48 hours of hospitalization were
included. The coefficients of variation (CoV, the ratio of the standard
deviation to the mean) of the blood sugar level were analyzed with
multivariate logistic regression models to test the association between in-
hospital mortality.
Results: Of the 1,537 patients included, most were older than 70 years of
age (median; 71, IQR: 59 to 80), male (54%), without a diagnosis of severe
sepsis (63%) and had a previous diagnosis of diabetes (84%). The initial
blood sugar levels of patients with and without previously diagnosed
diabetes were 259 ± 9.9 and 154 ± 5.7, respectively (mean ± SEM). The
CoV of the consecutively monitored blood sugar level during the first 48
hours of admission for patients with and without previously diagnosed
diabetes were 29.4 ± 0.5% and 21.0 ± 0.5%, respectively. Patients with
CoV lower than 10% and higher than 30% tended to have higher
mortality rate, compared to patients with 10 to 30% CoV level (11% vs.
12% and 7%, respectively, Figure 1). In the multivariate logistic regression
model adjusting for age, initial blood sugar level, severity of sepsis,
previous diagnosis of diabetes and diagnosis of severe sepsis, the higher
CoV level (>30%) was found to be associated with 60% increased odds of
in-hospital mortality (aOR: 1.61 ± 0.34); while the previous diagnosis of
diabetes was found to be associated with 45% lower odds of in-hospital
mortality (aOR: 0.55 ± 0.13, Table 1).
Figure 1(abstract P45) Lowess smoother plot for mortality versus coefficient of variation
Table 1(abstract P45)
Odds ratio Standard error P value 95% CI
Sugar CoV <10% 1.51 0.44 0.15 0.86 2.67
Sugar CoV >30% 1.61 0.34 0.02 1.06 2.43
Initial sugar level <100 0.98 0.01 0.00 0.97 0.99
Initial sugar level ≥ 100 and <500 1.00 0.00 0.67 1.00 1.00
Initial sugar level higher ≥ 500 1.00 0.00 0.54 1.00 1.00
Severe sepsis 2.43 0.48 0.00 1.65 3.56
Previous diagnosis of diabetes 0.55 0.13 0.01 0.34 0.88
Severity of sepsis 1.14 0.04 0.00 1.07 1.21
Age 1.01 0.01 0.49 0.99 1.02
Critical Care 2014, Volume 18 Suppl 2
http://ccforum.com/supplements/18/S2
Page 31 of 53
Conclusion: In this retrospectively cohort study, we found that increased
blood sugar variation was associated with worse patient outcome.
However, further study is merited to test the possible causal relationship
between variation of blood sugar level and patient outcome.
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Introduction: Sepsis occurs as a result of systemic inflammatory process.
The release of bacterial components to the systemic circulation leads to
activation of inhibitor kappa B kinase (IKK)-b and nuclear factor kappa B
(NF-B) through phosphorylation and ubiquitination. Excessive
inflammatory process with maladaptive host’s immune response leads to
organ dysfunctions and death [1,2]. This study was designed to
investigate association of the initial level of intracellular signalling
pathway and cytokine involved in sepsis pathophysiology (that is, IKK-b,
NF-B, tumour necrosis factor (TNF)a) and 72-hour (early) mortality in
severe sepsis patients.
Methods: A prospective cohort study was conducted in severe sepsis
patients (aged 18 years and older) admitted to the Emergency Unit of
Cipto Mangunkusumo Hospital, Persahabatan Hospital, and Gatot Subroto
Indonesia Central Army Hospital, Jakarta, Indonesia. All blood samples for
intracellular signalling pathway (that is, IKK-b, total NF-B, phospho NF-
B) and cytokine (that is, TNFa) were collected and measured using the
ELISA method during first 24 hours of inclusion. Patients’ outcome was
observed during first 72 hours after inclusion. Mann-Whitney test was
used to analyse the median difference of IKK-b, total NF-B, phospho NF-
B level in two groups based on 72-hour survival. The t test was used to
analyse the mean difference of TNFa levels in both groups.
Results: Subjects consisted of 90 patients. Early mortality developed in
27 subjects. Baseline characteristics of survival and death subjects are shown
in Table 1. The initial intracellular signalling pathway and cytokine
parameters level are shown in Table 2. There was a significant higher
median first 24 hours IKK-b and total NF-B level in survival subjects
compared with death subjects (P = 0.025 for median IKK-b and P = 0.036 for
median total NF-B). There was no significant difference of initial phospho
NF-B and TNFa level in survival and death subjects.
Conclusion: There is a significant lower initial IKK-b and total NF-B level
in severe sepsis patients surviving on 72-hour observation. There is a
tendency of lower initial phospho NF-B and TNFa level in severe sepsis
patients surviving on 72-hour observation.
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Introduction: The pre-existing inflammatory state influences the behavior
of infection, a first peak of inflammation may be the risk factor during
infection and predispose to a severe form of the disease [1,2]. This
hypothesis is frequently accepted but has never been tested. Patients with
hematological malignancies treated by chemotherapy in case of autologous
stem cell transplantation (ASCT) are exposed to a neutropenic state: an
abnormal low number of neutrophils. In the neutropenic patient, sepsis is
more frequent than in the non-neutropenic patient. The severity of infection
depends on many factors, particularly the pre-existing inflammatory state,
the genetic factors, and the duration and the depth of neutropenia. In the
literature, the factors involved in inflammation and infection are often
confused. On the other hand, no predictive transcriptomic signature of
sepsis was found. Our objective is to identify predictive genes that influence
the outcomes of the infection in neutropenic patients.
Methods: To test our hypothesis, high-throughput transcriptomic analysis
and bioinformatics will be combined, laying on the modulation of gene
expression of the peripheral blood mononuclear cells of patients with
hematological malignancies treated by chemotherapy in case of ASCT.
Results: A preliminary study on a reduced number of patients has allowed
us to assess the feasibility of the project. After a statistical analysis, 615
genes are differently expressed between patients who developed sepsis
and those who have not developed with a false discovery rate of 5%.
These 615 genes are potentially predictive of sepsis 2 days before the
development of the infection. Furthermore, 28 genes are differentially
expressed between patients who developed sepsis and those who have






Mean age (years) 52.98 ± 15.38 50.19 ± 13.46
Sex
Male 23 (36.5) 12 (44.4)
Female 40 (63.5) 15 (55.6)
Sepsis severity
Severe sepsis 42 (66.7) 13 (48.1)
Septic shock 21 (33.3) 14 (51.9)
Mean APACHE II score 13.03 ± 5.27 14.37 ± 6.55
Comorbidity
Without comorbidity 4 (6.3) 2 (7.4)
With comorbidity(s) 59 (93.7) 25 (92.6)
Source of infection
Respiratory tract 45 (71.4) 24 (88.9)
Intraabdominal 4 (6.3) 1 (3.7)
Skin and soft tissue 5 (7.9) 1 (3.7)
Urinary tract 2 (3.1) 1 (3.7)
≥ 2 sources 7 (11.3) 0
Mean procalcitonin (pg/
ml)
21.47 ± 44.30 30.26 ± 17.29
Mean baseline lactate
(mmol/l)
3.10 ± 1.77 4.89 ± 2.57
Data presented as n (%) or mean ± standard deviation. APACHE, Acute
physiology and chronic health evaluation
Table 2(abstract P46) Initial intracellular signalling






IKK-ba 0.10 (0.03) 0.12 (0,03) 0.025
Total NF-Ba 0.08 (0.08) 0.12 (0.08) 0.036
Phospho NF-Ba 0.10 (0.38) 0.33 (0.38) 0.579
TNFab 9.10 (7.80) 10.91 (11.74) 0.393
aMedian (interquartile range) in optical density, Mann-Whitney test. bMean
(standard deviation) in pg/ml, t test
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not developed with a false discovery rate of 5%, and these 28 genes are
potentially predictive of sepsis 7 days before the development of the
infection.
Conclusion: The ongoing transcriptomic study with a larger effect will allow
us to test our hypothesis and confirm the results of our preliminary study.
The microarray results should be strengthened with quantitative PCR assays,
than validated with protein assays. Finally, we will transfer the experimental
data to clinical practices.
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Introduction: Critically ill children often manifest acute kidney injury (AKI)
as part of their disease process with incidence up to 82% and it is
independently associated with poor outcome [1]. Sepsis is the most
common contributing factor and little is known about the pathogenesis of
septic AKI. There are no consistent histopathological changes in human or
experimental septic AKI [2]. Hence, understanding of the structural
changes associated with its occurrence is therefore important in the
management of AKI in critically ill children.
Methods: Children aged less than 12 years who died with septic AKI were
screened for percutaneous USG-guided kidney biopsy after obtaining
written informed consent from July 2012 to June 2014. Three cores of
kidney tissue were taken for histopathological evaluation by light,
immunofluorescence and electron microscopic examination. Sepsis and AKI
was defined using international pediatric sepsis consensus conference and
pRIFLE criteria respectively. Events related to death, laboratory parameters
and microbiological details 24 hours preceding death were recorded.
Results: A total of 40 kidney biopsies were done during the study period.
Median (IQR) age was 12 (2 to 36) months and PRISM-III was 14 (12 to 18).
The most common change was normal histology in 37.5% (n = 15)
followed by tubular change alone in 22% (n = 10), glomerular change
alone in 5% (n = 2) and blood vessel change in 2.5% (n = 1) of specimens.
Twelve specimens were showing a combination of changes (tubular +
glomerular + interstitium = 5; tubular + glomerular + blood vessels = 3;
tubular + glomerular = 2; tubular + interstitium = 1; tubular + glomerular +
interstitium + blood vessels = 1). All tubular changes were consistent with
acute tubular necrosis (ATN) and changes involved from 5 to 15% of
cortex. Thrombotic microangiopathy was diagnosed in 12.5% (n = 5) of
specimens. There were no significant difference between ATN versus non-
ATN groups with respect to baseline characteristics and events related to
mortality.
Conclusion: The most common change in septic AKI in critically ill
children is normal histology followed by ATN. This is consistent with
published literature [2].
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Introduction: Healthcare-associated infections (HAI) are a significant
problem in the pediatric intensive care unit (PICU). Apart from contributing
to mortality, they also increase the coast of PICU care [1]. Surveillance and
prevention of HAI by multifaceted quality improvement intervention
among critically ill children remain part of the standard of care [2].
Methods: The study was conducted in the 19-bed PICU of a tertiary care
referral academic institute. Data regarding ventilator-associated
pneumonia (VAP) and central line associated bloodstream infection
(CLABSI) using the CDC definition were collected prospectively from July
2013 to June 2014. Multifaceted quality improvement intervention
consisting of infection control nurse and physician and hand hygiene
education module and wearing a gown and mask during the care of
critically ill children was introduced from January 2014. Incidence of VAP
and CLABSI was compared before (July to December 2013) and after
(January to June 2014) introduction of the intervention.
Results: Before the intervention period, the incidence of VAP was 28.5
per 1,000 ventilation-days and CLABSI was 13.7 per 1,000 catheter-days.
After the intervention period the incidence of VAP was 13.3 per 1,000
ventilation-days and CLABSI was 8.3 per 1,000 catheter-days. The
proportion of patients ventilated for more than 48 hours who had VAP
was significantly less after intervention as compared to before the
intervention period (14.2%, n = 25/176 vs. 25.2%, n = 29/155; P = 0.012,
odds ratio (OR), 95% CI 0.49, 0.28 to 0.86). Both groups were similar with
respect to age, sex ratio, severity (PRISM-III), device utilization rate and
grade of infection. No significant difference occurred in overall PICU
mortality before and after intervention (28.2% vs. 28.9%).
Conclusion: Multifaceted quality improvement intervention results in
significant reduction of the healthcare-associated infection rate although
it was higher than reported from developed countries [1-3].
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Introduction: Sepsis, a leading cause of death in critical care patients, is the
result of complex interactions between the infecting microorganisms and
the host responses that influence clinical outcomes [1]. Reliable biochemical
markers that enable early diagnosis are still needed. A new marker,
presepsin (soluble CD14 subtype, sCD14-ST) is a circulating fragment of
13 kDa of soluble CD14 that originates from the cleavage of the CD14
expressed on the surface membranes of monocytes/macrophages. sCD14-ST
has been shown to increase significantly in patients with sepsis [2]. In our
study we compare diagnostic performance of presepsin, C-reactive protein
(CRP) and procalcitonin (PCT).
Methods: Critical patients with suspected sepsis admitted to the Unit of
Intensive Care of the University Hospital of Catanzaro (Italy) were
recruited into this study; healthy volunteers were also included as
controls. Plasma samples in EDTA from each patient were collected at
multiple time points; samples were tested for CRP, PCT and presepsin.
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Blood cultures were also evaluated and processed by a BacT/Alert 3D
system (bioMérieux, Italy); CRP was measured by immunonephelometry
(Siemens Healthcare Diagnostic, Italy) and PCT was assayed by an
enzyme-linked fluorescent assay (VIDAS BRAHMS PCT, bioMérieux, Italy);
presepsin levels were measured by rapid automated PATHFAST
immunoanalyzer (kindly provided by GEPA SRL, Italy), based on
chemiluminescent enzyme immunoassay. A statistical analysis was carried
out by Mann-Whitney test.
Results: Presepsin and PCT levels were significantly higher in culture-
positive subjects versus negative controls; such difference was found even
at the admission time. The presepsin values in worsening/dead patients
exhibited a significantly higher level at admission time. On the contrary, in
the same group of patients, PCT exhibited a decrease of its level. In poor
prognosis patients CRP showed a quite irregular kinetic, although in such a
group the admission value was higher than the same marker in live
subjects.
Conclusion: In this preliminary study, presepsin and PCT levels exhibited
substantial higher values in culture-positive patients. The kinetic curves of
presepsin, obtained from both survival and worsening/dead subjects,
revealed the optimal performance of this biomarker, particularly in severely
ill patients, as also shown in other studies. During sepsis, increase of
presepsin levels may be a more reliable marker, indicating an unfavorable
outcome [3,4]. Furthermore, high presepsin levels could alert clinicians not
to suspend antibiotic treatments even after clinical symptoms have
improved and PCT levels have returned to normal.
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Introduction: T-cell depletion is a marker of the hypo-inflammatory phase
of sepsis [1,2]. Systemic T-cell loss could be caused i.a. by thymus involution
during sepsis, thus contributing to immune paralysis [3]. Usually, thymic
T-cell egress is mediated by a sphingosine-1-phosphate (S1P) gradient. That
is, T cells leave the thymus towards an increased S1P-level in the periphery
(blood/lymph) [4]. A disruption of this S1P gradient blocks T-cell emigration.
S1P is produced by sphingosine kinases 1 and 2 (SPHK1 and SPHK2), which
are ubiquitously expressed [5]. Apoptotic cells are known to release S1P [6].
We suggest that apoptotic events in the thymus during sepsis increase S1P
levels, thereby disrupting the gradient and preventing egress of T cells from
the thymus.
Methods: We used a murine polymicrobial sepsis model to analyze thymus
involution. Sepsis is induced in wildtype mice, SPHK1-/-, or SPHK2-/- mice by
cecal ligation and puncture (CLP). Thymus involution was determined by
analyzing the T-cell amount of single-positive mature (CD4+CD8- vs. CD4-CD8
+), double-positive late immature (CD4+/CD8+), and double-negative early
immature cells by FACS analysis. T cells from SPHK1-/- or SPHK2-/- mice,
which produce less S1P, and wildtype mice treated with a SPHK1 inhibitor
were used to characterize whether T cells in these mice have a higher rate of
emigration compared to control mice. Thymic and serum S1P levels were
quantified by LC-MS/MS. Apoptosis was determined by annexin V FACS
staining. SPHK mRNA levels were determined by qPCR.
Results: The thymus of septic mice showed more CD3-positive cells but a
decreased number of CD4/CD8 double-positive T cells, pointing to a thymic
retention of single-positive mature T cells. In line with our assumption, CLP
causes apoptosis of thymocytes and increases SPHK1 mRNA expression.
Concomitantly S1P levels are increased in the thymus and consequently
decreased in serum following CLP. The knockout of the S1P producing
sphingosine-kinases SPHK1 or SPHK2 and the pharmacological inhibition of
SPHK1 restores T-cell egress as indicated by an increase of double-positive
immature T cells compared to wildtype mice.
Conclusion: Our data suggest that inhibition of SPHK1-mediated S1P
generation during sepsis restores thymic T-cell egress, which might improve
septic outcome. Therefore, understanding mechanisms of thymus involution
during sepsis may help to reconstitute thymic function, finally improving
immune reactions in the hypoinflammatory phase of sepsis.
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Introduction: Sepsis originates from an uncontrolled inflammatory
response. Despite intensive research, sepsis remains a major cause of death
in ICUs. Therefore, new therapeutic approaches are mandatory. Taking into
account that during sepsis progression cytotoxic T cells (CTL) are activated
in an autoimmune fashion contributing to multiorgan damage, it remains
unclear whether CTL are activated towards alloantigenic cells as well. This is
especially important for patients receiving an immune suppressive therapy
to permit organ transplantation and thus known to be at high risk for
developing sepsis. Therefore, we analyzed whether sepsis activates CTL
towards alloantigenic target cells and whether this can be inhibited by
PPARg activation, known to block T-helper cell responses.
Methods: To characterize whether sepsis activates CTL and whether this
can be inhibited by PPARg activation, we used an ex vivo cytotoxicity assay
to analyze CD8+ T-cell-dependent cytotoxicity. Responder CD8+ T cells
were isolated from C57Bl/6N PPARg wildtype (PPARgfl/fl) and T-cell specific
knockout (Tc-PPARg-/-) mice (haplotype H2Kb) following cecal ligation and
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puncture (CLP) versus sham treatment. P815 mastocytoma cells, a cell line
originally derived from DBA/2 mice (haplotype H2Kd), were used as
alloantigenic target cells. Pharmacological inhibition and/or activation of
PPARg in vivo and ex vivo was performed to clarify the impact of PPARg in
blocking CTL-dependent cytotoxicity. In vivo, PPARg activity in wildtype
mice was pharmacologically inhibited by the irreversible antagonist
GW9662 or induced by the thiazolidinedione rosiglitazone. Systemic
application of both compounds was performed intraperitoneally. A classic
splenocyte-driven stimulation protocol to activate CTL was carried out as
control.
Results: CTL isolated from septic mice showed enhanced cytotoxicity
towards alloantigenic P815 target cells. Enhanced cytotoxicity was effectively
reduced by both PPARg activation in vivo and ex vivo. In line, in CTL isolated
from T-cell-specific PPARg knockout (Tc-PPARg-/-) mice PPARg activation was
ineffective, strengthening a PPARg-dependent mechanism. At the molecular
level in vivo and ex vivo activation of PPARg reduced Fas and granzyme
B expression in activated CTL, which might explain reduced cytotoxicity.
Conclusion: Our study therefore suggests PPARg activation in vivo to
attenuate CTL-dependent alloantigenic cytotoxicity to possibly inhibit
acute organ rejection.
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Introduction: Infection and sepsis are common problems in cancer
management affecting up to 45% of patients. However, international
guidelines focus on the management of neutropenic fever, and fail to
address the recognition and resuscitation of patients who meet sepsis
criteria. Peter MacCallum Hospital is a 100 inpatient-bed tertiary cancer
hospital with hematology, medical oncology, cancer surgery and radiation
oncology, as well as a medical and chemotherapy day unit, apheresis, and
large ambulatory service but no emergency department. Records showed
that up to 25% of all in-hospital Medical Emergency Team (MET) calls were
attributable to sepsis with in-hospital mortality rates of up to 25%. We
aimed to identify barriers to effective management of inpatient sepsis at
Peter MacCallum Cancer Centre and to implement a hospital-wide sepsis
pathway.
Methods: A sepsis working party was formed with the antimicrobial
stewardship team, clinicians, and senior ambulatory and inpatient nurses.
Each member undertook direct observation and focus group interviews in
an allocated clinical area. Three key areas were examined: issues relating
the identification of sepsis, issues relating to clinical review of the patient,
and issues relating to timely administration of first dose of antibiotic.
Inpatient and outpatient issues were graphically represented in a process
map (Figure 1).
Results: Process mapping revealed significant gaps in knowledge in
medical and nursing staff and structural barriers to rapid resuscitation of
patients. There were significant knowledge gaps in the awareness of sepsis
diagnostic criteria, the role of lactate, effective fluid resuscitation, and the
need for early clinical review and referral to the ICU. Examples of structural
barriers to effective resuscitation included lack of availability of nurse
cannulators, availability of antibiotics, rapid intravenous fluid infusers and
sufficient after-hours medical and ICU liaison support. Knowledge and
structural barriers were systematically addressed during the implementation
of the clinical sepsis pathway. The sepsis pathway was designed as a
medical record form to be used across all clinical areas, and supports nurse
initiation. Following pathway implementation in March 2013 there have
been substantial improvements in the number of patients who have had a
lactate taken, received appropriate fluid resuscitation and time to first dose
of antibiotics. Administrative data shown in Figure 2 demonstrate increased
ascertainment of cases, and a fall in all-cause sepsis mortality after the
pathway was commenced.
Conclusion: Identifying knowledge gaps and structural barriers using
process mapping led to the successful design and implementation of a
sepsis program. The figures show that despite increased rates of coded
sepsis cases, mortality and ICU admission rates have not increased. Mortality
Figure 1(abstract P53) Portion of process map identifying barriers
to timely administration of antibiotics in the ambulatory setting.
RTx, radiotherapy department.
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of patients coded for sepsis March to October 2012 (13/56 (23.2%))
compared with those for March to October 2013 (10/121 (8.3%)).
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Introduction: Previous anti-inflammatory strategies against sepsis, a leading
cause of death in hospitals, had limited efficacy in clinical trials, in part
because they targeted single cytokines and the experimental models failed
to mimic clinical settings [1-3]. Neuronal networks represent physiological
mechanisms, selected by evolution to control inflammation, that can be
exploited for the treatment of inflammatory and infectious disorders [3].
Methods: Animal procedures were approved by the Institutional Animal
Care & Use Committee of the New Jersey Medical School of Rutgers
University. All animal experiments were performed in 6-week-old to 8-week-
old (~25 ± 5 g) male mice without any exclusion criteria. Experimental
sepsis: endotoxemia and CLP were performed as we previously described.
LPS was dissolved in sterile pyrogen-free PBS and sonicated for 30 minutes
immediately before use. Mice received a LD50 dose of LPS (6 mg/kg body
weight i.p.). LPS was added to the whole blood to a final concentration of
250 ng/ml for the in vitro procedures. Selective neurectomies and electrical
stimulations: all selective neurectomies and electrical stimulations were
performed in mice anesthetized with ketamine and xylazine. The electrical
stimulation in electroacupuncture and direct nerve stimulation (sciatic and
vagus nerves) was performed with a continuous-mode stimulation for
15 minutes with a electrical potential difference of 4 V, an electric current of
40 mA, a pulse width of 50 μs and a frequency of 10 Hz using an
electrostimulator.
Results: Here, we report that sciatic nerve activation with electro-
acupuncture controls systemic inflammation and rescues mice from
polymicrobial peritonitis. Electroacupuncture at the sciatic nerve controls
systemic inflammation by inducing vagal activation of aromatic L-amino
acid decarboxylase, leading to the production of dopamine in the adrenal
medulla. Experimental models with adrenolectomized mice mimic clinical
adrenal insufficiency [4], increase the susceptibility to sepsis and prevent the
anti-inflammatory effects of electroacupuncture. Dopamine inhibits cytokine
production via dopamine type 1 (D1) receptors. D1 receptor agonists
suppress systemic inflammation and rescue mice with adrenal insufficiency
from polymicrobial peritonitis. Our results suggest a new anti-inflammatory
mechanism mediated by the sciatic and vagus nerves that modulates the
production of catecholamines in the adrenal glands.
Conclusion: From a pharmacological perspective, the effects of selective
dopamine agonists mimic the anti-inflammatory effects of electroacupuncture
and can provide therapeutic advantages to control inflammation in infectious
and inflammatory disorders. Preliminary results in human clinical trials
indicate that electroacupuncture attenuates the postsurgical inflammatory
response decreasing the serum levels of inflammatory cytokines.
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Figure 2(abstract P53) Increased rate of sepsis at Peter MacCallum Cancer Centre from March 2013, coinciding with improved identification of
patients with sepsis.
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Introduction: Pneumonia is a common cause of death worldwide and the
leading cause of sepsis and shock in the ICU. Controlling excessive immune
stimulation with deleterious consequences for the host organs is a major
strategy in severe infections. In addition to viral dsRNA, the immune Toll-like
receptor 3 (TLR3) senses RNA released from injured tissues and necrotic cells
promoting excessive inflammatory cytokine release in pulmonary epithelial,
endothelial and immune cells. Thus, as a potent regulator of the lung
immune response, TLR3 represents a specific target to control damaging
inflammation in severe lung infections in combination with antimicrobials.
Here, we aimed to characterize potent small molecules displaying in vitro
and in vivo TLR3 blocker activities and develop several preclinical models to
investigate the role of TLR3 in pneumonia.
Results: We identified compounds with anti-TLR3 activity (IC50 = 50 nM)
through random screening and structure-activity relationship analysis by
testing small molecule libraries on recombinant hTLR3-HEK293 cells.
Selected compounds interacted with mouse and human TLR3, were
devoid of effect on TNFa-induced activation at 1 µM on HEK293 cells and
exhibited good early-ADME properties. Hit molecules also counteracted
PolyAU (PAU)/Poly(I:C) (PIC)-induced cytokine release (IL6, IL8, IP-10) on
human bronchial epithelial cells (BEAS-2B) expressing native TLR3
receptors. Interestingly, sustained stimulation of BEAS-2B by PAU/PIC (0.1
to 10 µM) to mimic viral activation induced overexpression of TLR3
mRNA, which was dose-dependently inhibited by these compounds, as
evidenced by RT-qPCR. In vivo, we confirmed the anti-TLR3 activity (3 to
30 mg/kg i.p.) against PAU/PIC (100 µg/mouse i.v.) but not flagellin-
induced plasma cytokine release in CD1 mice. To study these TLR3
inhibitors under pathological situations, we developed models of
Streptoccocus pneumoniae (ATCC6303) or Pseudomonas aeruginosa (PAO-
1)-induced pneumonia post influenza A virus (IAV PR/8/34 H1N1)
infection. Mice previously challenged with intranasal IAV showed
enhanced susceptibility to lung bacterial infections with a dramatic
mortality rate, whereas separately these pathogens are not lethal. In
addition, IAV/S. pneumoniae co-infected mice showed increased lung and
blood bacterial loads with severe inflammation signs evidenced by
elevated systemic IL-6 and KC levels and important lung tissue damages.
Currently, TLR3 blockers are ongoing evaluation in these models.
Conclusion: Immunomodulation and personalized treatments are
becoming relevant approaches to manage severe infections. Here, we
discovered the first small molecule probes targeting mouse and human
TLR3. These compounds efficiently control TLR3-triggered proinflammatory
response in vitro and in vivo and shape TLR3 overexpression in human
lung epithelial cells. They represent valuable pharmacological tools to
study the contribution of TLR3 in pneumonia and to propose new
adjuvant immunotherapies.
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Introduction: It is known that the systemic response during sepsis is caused
by proinflammatory mediators such as interleukin-1 (IL-1), interleukin-6 (IL-6)
and tumor necrosis factor alpha (TNFa). The inflammatory response in sepsis
causes disorders in the brain in addition to multiorgan dysfunctions including
the kidneys and liver [1]. Inducible nitric oxide synthase (iNOS) is induced in
hepatocytes by sepsis and mediates hepatic injury [2]. Matrix metallo-
proteinases (MMPs) play an important role in the formation of sepsis and
mediate inflammatory response and tissue damage [3]. On the other hand,
there are some cases in which systemic inflammatory response occurs
without the presence of infection such as epilepsy. Cytokines are well-known
inflammatory mediators in the brain, and they increase following seizures. We
previously demonstrated that pentyleneterazol (PTZ)-induced generalized
epileptic seizures significantly increased inflammatory markers (TNFa, IL-1b,
IL-6) in the brain and S100B in serum [4]. In this preliminary study, we aimed
to investigate the MMP2, MMP9, NOS, and myeloperoxidase activity in the
liver and kidney and levels of serum proinflammatory cytokines following
PTZ-induced generalized clonic-tonic seizures.
Methods: Adult Sprague-Dawley rats were divided into two groups as
Control and PTZ groups. The Control group was given saline and the PTZ
group was given 80 mg/kg PTZ i.p. Two hours after seizures, the rats
were decapitated and a cardiac blood sample was drawn, and liver and
kidneys were removed. Proinflammatory markers (IL-1bN, TNF-a, IL-6)
were investigated in serum by ELISA. eNOS, iNOS, MMP2, and MMP9
levels were analyzed immunohistochemically in the liver and kidney.
Results: Proinflammatory markers significantly increased in the serum of rats
after PTZ-induced seizures (Table 1). iNOS reaction was markedly increased
while eNOS reactions were decreased (Figure 1) in the liver of rats after PTZ-
induced seizures. MMP2 in the central vein of the liver and connective tissue
areas of liver and kidney tissues in the PTZ group were markedly increased
(Figure 2). MMP9 immune reaction in the PTZ group slightly increased in the
kidney and liver (Figure 3). MPO reactions, which are an indicator of
inflammatory activity, were markedly increased in both tissues (Figure 4).
Conclusion: The first findings show that long-term generalized clonic-tonic
seizures markedly increase markers that mediate inflammation (iNOS,
especially MMP2, MMP9, MPO) in the liver and kidney such as sepsis. In
addition, proinflammatory markers (TNFa, IL-1b, IL-6) were found
significantly high in serum. Thus, it is concluded that it will be worthwhile to
determine whether epileptic seizures cause sensitivity to sepsis.
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Introduction: Acute kidney injury (AKI) is a frequent and serious
complication of sepsis. Moreover, there is strong evidence that AKI in
patients with severe sepsis is associated with a higher mortality rate. The
Table 1(abstract P56) Proinflammatory cytokines in control
versus experimental groups
pg/ml Control PTZ
IL-1b 0.117 ± 0.042 0.775 ± 0.064
TNFa 0.062 ± 0.010 0.783 ± 0.044
IL-6 0.160 ± 0.012 0.0654 ± 0.026
*P < 0.001, compared to control one-way ANOVA and Benferroni for post hoc
were used. n = 7
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Figure 1(abstract P56) Immunohistochemical detection of iNOS and eNOS staining (arrows) in liver sections in control and experimental groups
(bar: 50 μm)
Figure 2(abstract P56) Immunohistochemical detection of MMP2 staining (arrows) in liver (A) and kidney (B) sections in control and
experimental groups. PT, proximal tubule; GL, glomerulus (bar: 50 μm)
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Figure 3(abstract P56) Immunohistochemical detection of MMP9 staining (arrows) in liver (A) and kidney (B) sections in control and
experimental groups. PT, proximal tubule; GL, glomerulus (bar: 50 μm).
Figure 4(abstract P56) Immunohistochemical detection of MPO staining (arrows) in liver (A) and kidney (B) sections in control and
experimental groups. PT, proximal tubule; GL, glomerulus (bar: 50 μm)
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devastating effects of Gram-negative sepsis are largely based on the effects
of lipopolysaccharide (LPS), also known as endotoxin. Mitochondrial
dysfunction has been suggested to contribute to the development of organ
dysfunction and failure in sepsis. The mitochondrial electron transport chain
consists of four complexes (CI to CIV) and its function can be assessed with
different approaches. Statins, such as simvastatin and atorvastatin, are
hypocholesterolemic drugs that possess pleiotropic effects, including
antioxidant and anti-inflammatory properties, that are either dependent on
or independent of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA
reductase) inhibition. In addition, in vitro and in vivo studies have
demonstrated that simvastatin has an anti-inflammatory effect in patients
with predialytic chronic kidney disease, and may play an important role in
counteracting the mechanisms involved in pathogenesis of inflammation.
We aimed to investigate the effects of prior simvastatin on mitochondrial
enzyme activities in kidney tissue of the early phase of sepsis.
Methods: We used male adult Wistar albino rats weighing 200 to 250 g in
the experiments. The rats were divided into four groups, each composed of
eight rats: control group, LPS group, Simvastatin group, Simvastatin + LPS
group. Lipopolysaccharide (LPS) from Escherichia coli O127:B8 (Sigma, St.
Louis, MO, USA) was injected intraperitoneally at a daily dose of 20 mg/kg,
Simvastatin (20 mg/kg) was given p.o. via oral gavage for 5 days. In the
Simvastatin + LPS-treated group, LPS was given 1.5 hours after the fifth dose
of simvastatin. Mitochondrial electron transport chain enzymes citrate
synthase, NADH-cytochrome c reductase (complex I + III), and NADH
dehydrogenase (complex I) were measured kinetically in spectrophotometer
from kidney tissue homogenate. The kidney tissue samples were fixed in
10% buffered formalin and embedded in paraffin for hematoxylin and eosin
(H&E) staining. Data were expressed as mean ± standard deviation (SD) and
analyzed during analysis of variance.
Conclusion: There were no changes in activities of citrate synthase, complex
I, complex I + III in tissue homogenate (P >0.05) (Figures 1 to Figure 3). In the
LPS + Simvastatin group, we found decreased activity of complex I compared
with those of the LPS and Simvastatin groups (P = 0.05, P = 0.07, respectively).
As a result of the light microscopic examination with H&E stained sections, we
observed tubule lumens widened and partially damaged in the epithelium. In
the Simvastatin group was seen partially widened tubular structure and even
in some areas tubular structure was found the same as control sections.
Moreover, the damage in tubular width and proximal epithelium was
observed to continue (Figure 4).
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Figure 1(abstract P57) Complex I activity (µmol/minute/g tissue)
Figure 2(abstract P57) Complex I + III activity (µmol/minute/g tissue)
Figure 3(abstract P57) Citrate synthase activity (µmol/minute/g
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Introduction: Muscular loss is a characteristic phenomenon induced by a
massive inflammation as occurring in sepsis. Indeed, the early phase of
sepsis is responsible for the expression of proinflammatory cytokines,
namely TNFa and IL-6, known to be effectors of cachexia. Although
cachexia is a morbidity factor in human, there is to date no animal model
of septic cachexia. The goal of this study is to create and characterize a
murine model of septic cachexia and evaluate endogenous ghrelin
variations. Among the factors involved in both sepsis and muscular
protection, current research highlights a potential role for ghrelin in
muscle protection but there are conflicting data regarding its variations
Figure 4(abstract P57) Hematoxylin and eosin staining in all experimental groups
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during experimental sepsis. In this study we evaluate its two circulating
forms (AG, acylated ghrelin and UAG, unacylated ghrelin).
Methods: Sixty male C57Bl6 mice (20 to 25 g, 6 to 8 weeks) were used
for these experiments. Sepsis is induced by a mild CLP (survival ≃ 80%).
After anesthesia, cecum is isolated, ligated at 1/3, and punctured twice
(21G needle). A laparotomy is performed without ligation or puncture.
Mice weight is followed every day, blood collections and hind limb
muscles dissection are realized at 2 hours, 6 hours, 1, 2, 3, 5 and 13 days
after CLP. Plasmatic cytokines (TNFa, IL-6) and ghrelin levels are
evaluated via the Luminex technique and ELISA assays respectively and
muscles are weighed.
Results: After surgery, weight loss in CLP mice significantly decreases from
D1 to D11 with a peak at D3 (20% vs. 10% for the Sham). On D12, septic
mice reach their original weight, which becomes identical to the Sham on
D13. Despite a similar weight, CLP mice muscles are lighter. Circulating TNFa
and IL-6 levels increase 2 hours after CLP and remain higher than for the
Sham operated mice. Ghrelin concentrations, regardless of its form, increase
after the surgery: AG rises on D1 and D2 while UAG increases earlier, from
2 to 24 hours.
Conclusion: We finalize a model of muscular and weight loss due to septic
conditions. Wasting syndrome and Inflammation are two of the three
conditions for cachexia. The next step is to determine proteolysis in our
model to confirm that we performed a murine model of septic cachexia. The
role of increased circulating levels of ghrelin in this model remains to be
elucidated.
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Introduction: Sepsis is a systemic reaction in the presence of an infection
characterized by an early systemic inflammatory response syndrome
followed by a compensatory anti-inflammatory response syndrome. The first
side of this typical immune response is responsible for widespread damage
organ whereas the second part leads to an immunoparalysis increasing
patients’ susceptibility to secondary infections. The goal of this study is to
finalize a murine model of sepsis to understand the physiopathology of
sepsis and eventually test new therapeutic approaches.
Methods: Male C57Bl6 mice (20 to 25 g, 6 to 8 weeks) were used. Sepsis is
induced by a mild CLP (survival ≃ 80%). Cecum is isolated, ligated (1/3), and
punctured twice (21G needle). A laparotomy is performed without ligation
or puncture. Blood is collected 2 hours, 6 hours, 1, 2, 3, 5 and 13 days after
the CLP. Plasmatic cytokines (TNFa, IL-6, IL-10) are evaluated via the
Luminex technique. Five days after CLP, splenocytes are collected and used
for immunological assays. Mice are intratracheally instilled with P. aeruginosa
5 days after CLP (5 × 106, 2 × 107 and 108 CFU) to evaluate survival.
Results: Circulating TNFa, IL-6 and IL-10 levels increase 2 hours after CLP
and remain high until the end of the experiment, as compared to Sham
operated mice. Five days after CLP, total T cells (T-CD3+) population and
proliferation significantly decrease as compared to the nonseptic condition
whereas the T-reg cell (T-CD4+/CD25+) population significantly increases
whereas it remains low in the Sham operated animals. TNFa induction by
LPS in cultured splenocytes increases both for CLP and Sham operated mice
but remains lower in septic mice. Survival following a secondary infection
decreases while the quantity of instilled P. aeruginosa increases. No mortality
is observed for 5 × 106 CFU, 50% of CLP die with 2 × 107 CFU and 100% of
mortality is observed for both CLP and Sham with 108 CFU. Two days after
instillation, P. aeruginosa is detected in the lungs of CLP and Sham but in
the spleen and liver only for CLP mice.
Conclusion: This study demonstrates that immunosuppression following
CLP increases mice susceptibility to secondary P. aeruginosa intratracheal
infection. However, this susceptibility depends on the bacterial load.
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Introduction: Metabolism of tyrosine can be switched in conditions of
hemodynamic instability and tissue hypoperfusion. The violation of the
oxygen-dependent metabolism of tyrosine must be accompanied by the
activation of alternative pathways (Figure 1). Previously, we found a high level
of content in the blood of aromatic intermediates p-hydroxyphenyllactic acid
(p-HPLA) and p-hydroxyphenylacetic acid (p-HPAA) in patients with sepsis
[1,2]. We assume that the anaerobic microbiota can take an important part
in biodegradation of excess alternative metabolites of aromatic amino
acids [3,4].
Methods: Serum samples were collected from critically ill patients (n =
65) with surgical diseases (n = 32), brain injury (n = 22), and lung
diseases (n = 11). Patients were included in the study on the day of
admission to the ICU. The median of age was 62 (IR 42 to 77) years, the
APACHE II score was 17 (IR 11 to 29). The level of p-HPLA and p-HPAA
were measured in serum using GC-FID. Anaerobic bacteria (Figure 2) were
cultured in Shedler media, and the level of aromatic metabolites were
measured before and after 48 hours of incubation using GC-MS. Data
were compared by Mann-Whitney U test, P < 0.05 considered significant
(IBM SPSS Statistics 22).
Results: In surviving patients (n = 24) the total level of p-HPLA and p-
HPAA (4.47; 3.24 to 8.35 µM) was less (P < 0,001) than in patients who
died (n = 41) (13.67; 5.78 to 52.26 µM). The severity of organ dysfunction
on a SOFA scale correlates (rs = 0.7, P < 0.001) with the total level of the
p-HPLA and p-HPAA. Also the total level of aromatic compounds
correlates with lactate (rs = 0.6; P < 0.001), BE (rs = -0.5, P < 0.001) and
perfusion blood pressure (rs = -0.5, P < 0.001). ROC analysis revealed that
p-HPLA has the largest area under the curve (0.78; CI 0.67 to 0.90, P <
0.001). In experimental studies, anaerobic bacteria significantly reduced
the level of p-HPAA and p-HPLA (Figure 2).
Conclusion: High level of p-HPLA and p-HPAA correlate with severity and
mortality of patients. Hypoxia can be one of the leading mechanisms of
tyrosine metabolism disorders in critically ill patients. Bacteroides spp. are
able to consume p-HPLA and p-HPAA and consequently may be involved
in the elimination of these intermediates from the human body mutually
with endogenous mechanisms of detoxification.
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Introduction: Survival from sepsis and bloodstream infections (BSI) often
depends upon rapid identification of the infecting pathogen and
expeditious antimicrobial therapy. We report findings from the final
analysis of RADICAL, a multicenter observational study that compared
results from direct blood specimen testing using PCR/ESI-MS to standard
microbiology in critically ill patients.
Methods: Eight ICUs in six European countries participated. Patients with
suspected infection plus ≥2 new onset SIRS criteria were enrolled and
had an extra blood specimen taken for PCR/ESI-MS direct analysis. Results
were compared to standard of care microbiology. All patients were
followed up to 28 days or until inpatient death or discharge. A panel of
three independent physicians reviewed a summary of each case to
determine the potential impact upon patient management if results had
been available for decision-making.
Results: A total of 609 direct blood specimens from 543 patients meeting
inclusion criteria were tested. Patient demographics and organ failure
criteria observed were consistent with previously published sepsis studies.
Figure 1(abstract P60)
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Culture/PCR comparisons were as follows: +/+ 54; +/- 13; -/ + 169; and -/-
393, respectively, for a sensitivity of 81%, specificity of 69%, PPV of 24%
and NPV of 97%. The distribution of the organisms in the culture-/PCR+
group was similar to the culture+/PCR+ group and was reproducible in
replicate testing with an independent blood draw. Analysis of additional
sample types (lower respiratory tract or sterile fluids and tissues)
corroborated direct blood findings in 58% of cases where multiple
specimens from the same patients were analyzed. The independent
expert panel would have considered a different course of care in 57% of
the cases when PCR/ESI-MS was positive, 41% of which would have
resulted in altered, instituted, or ceased antibiotic therapy, earlier.
Conclusion: These results suggest that PCR/ESI-MS accurately detects the
infecting pathogen in critically ill patients with BSI, and that its use might
often lead to a different treatment. The test’s ability to rule in or rule out
infection approximately within 8 hours of the blood draw has added
potential clinical and economic benefit, as it might minimize unnecessary
use of antibiotics.
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Introduction: Lipidose (formerly GR270773) is a protein-free
phospholipid emulsion intended for the treatment of hospitalized
patients with suspected or confirmed Gram-negative severe sepsis.
Lipidose contains phosphatidylcholine, triglyceride and sodium cholate
formulated to optimize delivery of the phospholipid component to the
surface of high-density lipoprotein (HDL) and other lipoproteins, thereby
enhancing the capacity of the patient’s circulating lipoprotein pool to
bind and neutralize microbial toxins. When Lipidose is infused into
blood, the cholic acid is adsorbed onto serum albumin and the
phospholipid selectively associates with lipoproteins. Bound and
neutralized toxins are removed from the circulation by the liver and
excreted along with the cholic acid into the bile. The LIPOS trial
enrolled 1,400+ patients at 235 study centers in 31 countries to access
Lipidose treatment at two dose levels. The LIPOS headline data
presented only a small mortality benefit for the lower dose and no
benefit from the higher dose [1]. A subgroup analysis was carried out to
test the hypothesis of benefit in the subgroup with adequate liver
function, using serum albumin levels as a measure of liver function, and
adequate pre-existing HDL or total lipoprotein to accept phospholipid
as predicted by the mechanism of action.
Methods: Albumin, cholesterol and HDL were measured in stored serum
samples. The response to treatment and interactions with baseline
covariates specified in LIPOS were tested after exclusion of subjects in
the lowest biomarker quartiles (AlbTC25 and AlbHDL25).
Results: Subjects above the lowest quartile of albumin cleared Lipidose
significantly faster than those in the lowest quartile (P < 0.003). Interactions
between treatment and planned use of intravenous stress replacement
doses of corticosteroids (IVCST) were found in the AlbTC25 and AlbHDL25
subgroups (P < 0.05). Exclusion of these subjects revealed strong
relationships between treatment benefit and cholesterol or HDL that were
used to select optimal biomarker thresholds. Requiring albumin ≥1.5 g/dl
and either cholesterol ≥1 mM or HDL ≥0.5 mM selected 59% and 36%,
respectively, of the LIPOS population. Treatment with Lipidose reduced
mortality in these subgroups by 6.6% (P < 0.025) or 10.8% (P < 0.005)
respectively. The treatment benefits persisted for at least 1 year.
Conclusion: A strong negative interaction with IVCST may have masked a
significant treatment benefit in LIPOS. This interaction may be related to
the ability of bile acids to slow clearance and raise concentrations of
corticosteroids [2,3]. Biomarkers can be used to select subjects with early
severe septic shock responsive to treatment with Lipidose.
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Introduction: A clinical suspicion of infection is mandatory for diagnosing
sepsis in patients with a systemic inflammatory response syndrome. Yet
the accuracy of categorizing critically ill patients presenting to the ICU as
being infected or not is unknown. We therefore assessed the likelihood of
infection in patients who were treated for sepsis upon admission to the
ICU, and quantified the association between plausibility of infection and
mortality.
Methods: We studied a cohort of critically ill patients admitted with
clinically suspected sepsis to two tertiary ICUs in the Netherlands between
January 2011 and December 2013. The likelihood of infection was
categorized as none, possible, probable or definite by post hoc assessment.
We used multivariable competing risks survival analyses to determine the
association of the plausibility of infection with mortality.
Results: Among 2,579 patients treated for sepsis, 13% had a post hoc
infection likelihood of ‘none’, and an additional 30% of only ‘possible’. These
percentages were largely similar for different primary suspected sites of
infection. In crude analyses, the likelihood of infection had no impact on ICU
mortality, but was associated with increased length of stay and complications.
In multivariable analysis, however, patients with an unlikely infection had a
higher mortality rate compared to patients with a definite infection
(subdistribution hazard ratio 1.23; 95% confidence interval 1.03 to 1.49).
Conclusion: This study is the first prospective analysis to show that the
clinical diagnosis of sepsis upon ICU admission corresponds poorly with the
presence of infection on post hoc assessment. A higher likelihood of
infection does not adversely influence outcome in this population.
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Introduction: Community-acquired pneumonia (CAP) is the most common
infectious reason for admission to ICUs and has mortality of up to 37% [1].
Highest mortality rates are in Gram-negative infections with lower rates in
Streptococcus pneumoniae and viral infections [2]. Microbiology is difficult
to establish with most prospective studies identifying agents in only 50%
of cases [3]. We analysed microbial aetiology of CAP in ICU over 1 year and
assessed its effects on inpatient mortality, length of mechanical ventilation
and length of ICU stay.
Methods: We retrospectively reviewed admissions to AMNCH ICU between
February 2013 and February 2014 catalogued as having pneumonia from
chest radiograph and clinical findings on the internal audit system (n = 91).
After chart review, 28 were excluded as hospital-acquired pneumonias, 12
due to insufficient information and 21 due to primary diagnosis other than
pneumonia. Thirty patients were selected on the basis that CAP was the
likely reason for ICU admission.
Results: Pathogens were detected in 73% of patients by culture, antigen
detection or molecular methods: S. pneumoniae (n = 6; 20%), influenza (n =
4; 13%), viral with superimposed bacterial infection (n = 4; 13%), viruses
other than influenza (n = 3; 10%), Gram-negative bacilli (n = 2; 7%),
Legionella spp. (n = 2; 7%) and Haemophilus spp. (n = 1; 3%). No organism
was identified in 27%. Gram-negative infection had highest mortality
(100%), average length of mechanical ventilation (57 days) and average ICU
stay (64 days). The mean age of affected patients was 68.2. Mortality was
lower in influenza/other viral infections (75/50%), patients spent less time
mechanically ventilated (mean 6.6/13.3 days) and less time in ICU (mean
4/16.3 days), reflecting the younger mean age of patients (53.2/51.4). Of
patients infected with S. pneumoniae, Legionella spp. or Haemophilus spp.
alone, all survived to discharge. However, of note, when superimposed on
viral infection, these pathogens carried a higher mortality (50%). Infection
with pneumococcus alone occurred in younger patients (mean age 50.6)
and was associated with a shorter ventilation period (mean 2.66 days) and
ICU stay (mean 6 days).
Conclusion: Microbial aetiology was identified in a high proportion of
patients (72%) admitted to ICU with CAP, reflecting timely collection of
appropriate specimens. Infection with Gram-negative organisms had the
highest mortality, length of mechanical ventilation and length of ICU stay,
while the pathogens usually seen in CAP were associated with more
favourable outcomes.
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Introduction: Maintenance of the integrity of the endothelial barrier is
crucial in pathological inflammatory/infectious conditions [1]. The
endothelial barrier dysfunction leading to increased vascular permeability
and leukocyte transmigration in the systemic inflammatory state has been
intrinsically related to the multiple organ dysfunction syndrome. The Rho
GTPases family regulates the organization of the actin cytoskeleton, and
plays a fundamental role in maintaining homeostasis and function of the
endothelial barrier [2]. The study of the mechanisms of intracellular signaling
related to the integrity of the endothelial barrier may help in understanding
the hemodynamic changes during systemic infection. Thus, this study aimed
to correlate the pattern of genic expression of GTPases during the initial
periods of sepsis in order to understand the kinetic of these molecular
mechanisms in organs often affected in sepsis.
Methods: Wistar rats weighting 200 to 250 g were submitted to: nonlethal
sepsis (2 ml Escherichia coli 107 UFC/ml i.v. inoculation [3,4], n = 5, S7
group); minor trauma (cervical incision with catheter implantation in
jugular, injection of 2 ml saline, n = 5, SHAM group); without any
procedure (n = 5, NAIVE group). After 2 and 6 hours, the liver and kidney
were collected to determine RhoA, Rac1 and Cdc42 gene expression by
quantitative real-time PCR.
Results: Low expression of RhoA was observed in both organs (Figures 1A
and Figure 2A). Rac1 and/or Cdc42 showed higher expression in both organs
in animals submitted to systemic infection (S7 group) compared to the
SHAM and NAÏVE groups in both periods (Figures 1B, C and Figure 2B, C).
Although both organs showed a similar pattern, the kidney showed a
statistically significant increase of Cdc42 and Rac1 as compared to the liver,
showing that GTPase expression might differ, possibly due to endothelial
heterogeneity of each organ to perform its specific function. These results
suggest that the infectious process leads to a higher gene expression of Rac1
and/or Cdc42 in relation to a minor surgical trauma inflammation. The RhoA
and Rac1 gene expression were inversely correlated, as reported in the
literature [5].
Conclusion: Rac1 and Cdc42 possibly act in favor of preserving the
integrity of the endothelial barrier by their attributed stabilization and
protection of microvessel endothelial cells, by gathering the cell junctions
during the infectious state. Studies are being conducted to better
understand the mechanisms of intracellular signaling of the endothelial
barrier in different organs of animals submitted to varying degrees of
systemic infections.
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Figure 1(abstract P65) Gene expression of GTPases RhoA (A), Rac1
(B) and Cdc42 (C) in the liver of rats. Animals were subjected to
nonlethal sepsis 2 ml Escherichia coli 107 UFC/ml i.v. inoculation
(S7 group), minor trauma 2 ml saline i.v. inoculation (SHAM group), or
animals without inoculation were used as control group (NAÏVE group).
After 2 or 6 hours the kidney was isolated. Total RNA was extracted and
transcribed to cDNA. Gene expression was quantified by real-time PCR.
Graph bars show the relative concentration of each cDNA compared
with the NAIVE group and the housekeeping gene HPRT. Results are
mean ± SEM (n = 5 animals/group) and analyzed in triplicate. *P < 0.05
compared to NAÏVE group
Figure 2(abstract P65) Gene expression of GTPases RhoA (A), Rac1
(B) and Cdc42 (C) in the kidney of rats. Animals were subjected to
nonlethal sepsis 2 ml Escherichia coli 107 UFC/ml i.v. inoculation (S7
group), minor trauma 2 ml saline i.v. inoculation (SHAM group), or
animals without inoculation were used as control group (NAÏVE group).
After 2 or 6 hours the kidney was isolated. Total RNA was extracted and
transcribed to cDNA. Gene expression was quantified by real-time PCR.
Graph bars show the relative concentration of each cDNA compared
with the NAIVE group and the housekeeping gene HPRT. Results are
mean ± SEM (n = 5 animals/group) and analyzed in triplicate. *P < 0.05
compared to NAÏVE group
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Introduction: Throughout the world, the number of patients at risk for
bloodstream infections (BSIs) continues to rise. BSIs are associated with
high rates of morbidity and mortality, and they markedly increase the
costs of hospital care. Prompt identification of the causative agent(s) and
rapid initiation of appropriate antimicrobial therapy are critical for
reducing mortality, especially in patients with septic shock. Matrix-assisted
laser desorption-ionization time of flight (MALDI-TOF) equipment is
increasingly used in the microbiological laboratory. The goal of the present
investigation was to apply mass spectrometry directly from positive blood
cultures in order to detect and identify bacterial strains using a simplified
homemade protocol.
Methods: One-hundred and sixty-six positive blood cultures (Bactec FX;
Becton Dickinson) were analyzed. Gram and conventional plates were used
and the identification was done by Wider System (Soria Melguizo). In the
MALDI-TOF protocol, positive blood cultures were processed as follow: 5 ml
sample of positive broth was extracted and centrifuged at 1,000 rpm for
10 minutes in order to remove blood cells. The supernatant was collected
and centrifuged at 4,000 rpm for 15 minutes, then the supernatant was
removed and the pellet was placed directly onto a MALDI-TOF target plate
and dried at room temperature, subsequently adding 1 μl HCCAMatrix
solution (10 mg/ml cyano-4-hydroxycinnamic acid) and drying. Mass spectra
were acquired with a Microflex LT mass spectrometer using FlexControl 3.3
software (Bruker Daltonics GmbH).
Results: One-hundred and forty-nine (89.7%) blood cultures were correctly
detected. Thirty-three bacterial species were identified as being Escherichia
coli (47), the most frequent, followed by Pseudomonas aeruginosa (14),
Enterobacter spp. (11), Klebsiella spp. (9), Staphylococcus aureus (9),
coagulase-negative staphylococci (9), Enterococcus spp. (8), Bacteroides spp.
(7) and streptococci (6). Bacteria fastidious as Burkholderia, Raoultella, Delftia,
Listeria, Acinetobacter or Stenotrophomonas were correctly identified. Only
one strain of Streptococcus pyogenes and 14 strains of coagulase-negative
staphylococci cannot be identified. In hemolyzed samples, it was not
possible to identify two strains of S. aureus.
Conclusion: Using MALDI-TOF MS for bacteria identification directly from
blood cultures represents an advance in the treatment of septic patients.
Compared with conventional culture-based methods, this approach can
improve species-level identification of bloodstream isolates in terms of
time, accuracy, and costs. We conclude that this technique is simple, fast
and reliable for direct bacterial detection from positive blood cultures.
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Introduction: Sepsis is a complex and heterogeneous syndrome in which
inflammatory and infection mechanisms are implicated. Thus, it is difficult to
differentiate those mechanisms in mammals where inflammation is a highly
complex biological process. In our laboratory, besides studying sepsis in
human blood biological samples, we choose to investigate a murine model
in ordered to describe a global transcriptome overview of critical events
occurring in the blood, brain and lung during an induced non-infection
inflammation. We decided to complete our view with another animal model
where the inflammatory process is less complex and mainly achieved
through innate immunity Drosophila melanogaster.
Methods: Female C57BL6/J mice received an intravenous oleic acid (OA)
injection to induce a controlled inflammation. Lung, brain and peripheral
blood mononuclear cell (PBMC) expression patterns were analyzed using an
Agilent 60K cDNA mouse microarray. The enrichment of canonical pathways
revealed marked changes in pathways involving the immune and
inflammatory responses. The inflammatory process in D. melanogaster
shares common mechanisms in innate immunity with mammals (Toll
pathway/TLR). We decided to set up a model, called the double-hit model,
where drosophila females aged from 7 to 10 days have been injured with a
needle (inflammatory hit) before being infected with a needle that has been
dipped in a bacterial solution of Pseudomonas entomophila (infectious hit).
The next step will be to investigate the transcriptome in order to highlight
the differences and have a global view of biological mechanisms involved;
and also look for genetic factors involved in this experiment. The DGRP
(Drosophila Genomic Reference Panel) project is a panel of 200 inbred fly
lines that have been fully sequenced.
Results: Strikingly, in mice models, all significant pathways identified in the
brain were also significant in the lung. The inflammatory responses
oscillated between proinflammatory and anti-inflammatory response in both
the lung and brain, the time course, however, being different in the two
organs. In PBMC, we observed a significant response delay after OA injection
and the pathways identified differed from those identified in the lung and
brain. Our second objective will be to use this model of the expression to
set up a tool to analyze precisely the effect of an infection in a second hit
during the sterile inflammation activation/repression time courses. In D.
melanogaster, we recorded their survival in comparison with flies that only
received the infectious hit and observed a difference of ~40%. Flies that
have received a non-infectious double-hit showed a 10% decrease in
survival rate. We will perform the double-hit experiment with all the lines of
the DGRP and then through genome-wide association study. We expected
to identify single nucleotide polymorphisms that are associated with
resistance or susceptibility to the double-hit.
Conclusion: In mice, we assessed gene expression profiles in mouse lung,
brain and PBMC associated with a lung inflammation during a 24-hour
time course. Overall, our microarray analysis provides a global and detailed
overview of critical transcriptional events occurring in the blood, brain and
lung. The analysis of gene functional annotation revealed several major
features. First, many genes were upregulated or downregulated over the
time in the lung, brain, and blood. Second, the analysis revealed pathways
clearly related to inflammation mainly in the lung and brain. The strong
inflammation observed in the brain, and a limited inflammation in
the blood, indicates that blood gene expression profiles poorly reflect
those observed in the lung and brain. Third, all the pathways identified in
the brain were also identified in the lung, although a few common genes
were characterized; it should also be stressed that there was a delay
response in the brain.
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Introduction: Mycoplasma organisms are the smallest bacteria capable of
self-replication [1] and include species capable of causing disease (for
example, Mycoplasma pneumoniae, Mycoplasma genitalium) as well as those
that are generally thought to exist synergistically with their human host (for
example, Mycoplasma salivarium). The Edinburgh critical care group (Prof TW/
ACM) has recently identified a high prevalence of M. salivarium in the
bronchoalveolar lavage washings from patients with confirmed and
suspected ventilator-associated pneumonia (VAP) (Figure 1) [2]. The aim of
this study was to examine the effect of M. salivarium on human immune cells
in vitro. Specifically, we measured cytokine production and phagocytosis
activity in response to M. salivarium exposure.
Methods: Whole human blood was obtained from healthy donor
volunteers and cell types were isolated using diffusion gradients and
magnetic labeling as appropriate. Monocytes and macrophages were
incubated with M. salivarium for 24 hours before a subsequent LPS stimulus.
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Macrophage phagocytosis assays were conducted after exposure times of 60
minutes and 24 hours to M. salivarium. Cytokines were measured using
ELISA and human cytokine bead array kits.
Results: There was a statistically significant decrease in phagocytosis
between control cells and the macrophages exposed to both a low titer
of M. salivarium (P value 0.018) and a medium titer of M. salivarium
(P value 0.011) after 24 hours of exposure (Figure 2). There was a
statistically significant decrease in phagocytosis activity between the
macrophages exposed to the medium titer of M. salivarium for 24 hours
versus 60 minutes (P value 0.013). Exposure of macrophages to
mycoplasma resulted in decreased release of TNFa after a subsequent
LPS stimulus (Figure 3). To our knowledge, this is the first time
extracellular traps have been induced in macrophages in response to
M. salivarium (Figure 4).
Conclusion: Although further research is needed, it is interesting that the
presence of M. salivarium caused an anti-inflammatory effect as well as
impaired antigen presentation secondary to impaired phagocytosis. This
could be consistent with the better outcome in mechanically ventilated
patients that did not have M. salivarium bacteria detected in their
bronchoalveolar lavage washings. Extracellular traps contribute to microbial
containment by forming a physical barrier composed of chromatin and
cytoplasmic proteins to enhance antimicrobial synergy while minimizing
damage to host tissues [3]. It is interesting that M. salivarium induced
extracellular traps.
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Introduction: The gut is the largest immune organ and plays a central role
in the promotion of systemic inflammatory responses [1]. Perturbations of
intestinal epithelial homeostasis during sepsis include increased
proinflammatory cytokine production, increased intestinal permeability and
apoptosis [2-6]. Healthy gut is essential to promote host health and prevent
organ dysfunction in sepsis. Probiotics seem to keep gut homeostasis
through different pathways, such as the modulation of microbial activity,
energy regulation, anti-inflammatory cytokine production, gene expression
Figure 1(abstract P68) Combined mycoplasma detection by PCR in
the prospective and clinical groups
Figure 2(abstract P68) Twenty-four-hour exposure of macrophages
to Mycoplasma salivarium.
Figure 3(abstract P68) Mycoplasma salivarium (30,000) for 24 hours
prior to 100 ng/ml LPS exposure
Figure 4(abstract P68)
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and cell differentiation [7]. Probiotics have been shown an effective
treatment in various clinical conditions, although the potential benefits of
probiotic treatment in sepsis remain largely undefined. The aim of the
present study was to investigate the effect of probiotic treatment on gut
dysfunction and inflammatory signaling in septic rats.
Methods: Sepsis was induced by cecal ligation and puncture (CLP) in
Wistar male rats (8 weeks old). They were pretreated with probiotics or
vehicle once a day during 7 days before CLP. The chosen probiotic
mixture contained 10 × 107 CFU Bifidobacterium longum, 10 × 106 CFU
Lactobacillus bulgaricus, 10 × 106 CFU Lactobacillus acidophilus. Colonic
tissue and serum samples were collected 24 hours after CLP for ELISA
and protein expression analysis by western blotting.
Results: Our data demonstrate that probiotic pretreatment improved
survival of septic rats (Figure 1) and this effect is accompanied by a
marked decrease of IL-1b and TNFa (Figure 2A,B). Sepsis leads to severe
intestinal epithelial damage with a decrease in claudin 2 and occludin
protein expression (Figure 3A,B); probiotic pretreatment reversed these
alterations in parallel with an increase in Hsp72 and Hsp25 activation
(Figure 4A,B). In intestinal epithelial cells, the inducible Hsp have been
shown to preserve tight junction and barrier function. The maintenance
of epithelial barrier integrity induced by probiotic pretreatment, in
parallel with an activation of cytoprotective pathway, may culminate in
the restoration of the intestinal epithelial function.
Conclusion: Our results show that probiotics pretreatment fulfills a dual
function at the intestinal mucosa: in addition to preventing intestinal
permeability disruption, it also attenuates proinflammatory cytokine
release, diminishing the exacerbate host’s reaction to infection and
offering a novel prophylactic strategy to sepsis.
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Introduction: The amount of fluid during resuscitation of septic shock is
important. Too little fluid may result in tissue hypoperfusion; however, too
much fluid may result in volume accumulation. Several recent studies have
demonstrated that a positive fluid balance in critical illness is associated
with deteriorating outcomes. However, some studies have shown opposite
results. The objective of this study was to determine whether initial fluid
balance in septic shock patients is correlated with ICU mortality.
Methods: This is a retrospective study of septic shock patients admitted to
a mixed medical-coronary care unit of Songklanagarind hospital from 2005
to 2011. Multivariate logistic regression analysis was used to identify
predictors of mortality.
Results: A total of 1,048 patients admitted to ICU for septic shock was
divided into two groups: in-ICU survivors (n = 555 (53%)) and nonsurvivors
(n = 493 (47%)). Median survival time was 10 days (95% CI: 8 to 12 days).
The respiratory tract was the most common site of infection (47.6%).
Community-acquired infections accounted for 59.6%. Survivors were older
than nonsurvivors (62 vs. 56 years, P = 0.016). Nonsurvivors were more
severely ill and had shorter ICU stays (2 vs. 5 days, P < 0.001). Nonsurvivors
received albumin and steroid more than survivors. Median cumulative fluid
at 24, 48 and 72 hours of septic shock onset were 4.2, 7.7 and 10.5 l
respectively. Nonsurvivors had significantly larger median cumulative fluid
intake at 24 hours (4.6 vs. 3.9 l, P < 0.001), at 48 hours (8.2 vs. 7.1 l, P <
0.001) and at 72 hours (11.4 vs. 9.9 l, P < 0.001). Nonsurvivors also had
Figure 1(abstract P69)
Figure 2(abstract P69)
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significantly larger fluid balance (5.4 vs. 4.4 l, P < 0.001) and mean fluid
balance (2.8 vs. 1.6 l, P < 0.001) within 72 hours. In multivariate logistic
regression analysis, factors significantly associated with ICU mortality were
mean fluid balance, APACHE II score, SOFA score, length of ICU stay, ARDS,
steroid use, parenteral nutrition use and source of infection.
Conclusion: A more positive cumulatively fluid balance over 3 days is
associated with ICU mortality in septic shock. Multivariate analysis found not
only nonmodifiable factors such as severity score, source of infection, length
of ICU stay and ARDS, but also modifiable factors such as parenteral
nutrition use, steroid use and mean fluid balance were significantly
associated with mortality.
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Introduction: Pathophysiological mechanisms of sepsis-associated
encephalopathy involve oxidative stress. This imbalance between the pro-
oxidant and antioxidant causes damage to macromolecules such as lipids
and proteins, thus the employment of antioxidants becomes an attractive
proposition. Alpha lipoic acid (LA), a potent antioxidant, is able to cross
the blood-brain barrier, and is an important cofactor in enzymatic and
cellular energy metabolism. We aimed to determine the use of AL in
oxidative damage and neutrophil infiltration in rat brain 12 and 24 hours
after induction of sepsis model by cecal ligation and puncture (CLP).
Methods: Male Wistar rats (250 to 350 g) were subjected to CLP model,
with sham control. Groups were divided into sham + saline, sham + AL,
CLP + saline and CLP + AL (200 mg/kg orally with single administration
after CLP), n = 10. At 12 and 24 hours, rats were euthanized, the
hippocampus, striatum, cerebellum, cortex and prefrontal cortex removed,
lipid peroxidation assessed by TBARS, damage to proteins by protein
carbonylation, myeloperoxidase activity (MPO) and the formation of
nitrite and nitrate. Data were analyzed by ANOVA with post hoc Tukey
test and log-rank test with P < 0.05.
Results: In 12 hours compared with the CLP group, the CLP + AL group
showed a reduction in lipid peroxidation in the striatum, in the protein
carbonylation in the cortex and hippocampus, in the MPO activity in the
striatum and hippocampus, and decreased formation of nitrite and nitrate
in the hippocampus and cortex.
Conclusion: While differences were not observed in 24 hours, TBARS
found protein carbonylation in a reduction of damage to the CLP + AL
group over the cerebellum, MPO in the striatum, hippocampus and
prefrontal, and hippocampus, cerebellum, and prefrontal to nitrite/nitrate.
AL may be an important therapeutic target in reducing neurologic
complications in animal models of sepsis.
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Introduction: Septic shock is a medical emergency that, despite the
medical advances that have been made, still remains a major cause of
hospital deaths. Cell therapy is an innovative field of research that could
provide a therapy for sepsis. Mesenchymal stromal cells (MSC) are
promising in cell therapy and more importantly for sepsis because of
their immunosuppressive capabilities [1]. MSC have been shown by
several groups to have a positive effect against sepsis in vivo [2-4]. It has
been predicted that the MSC interact with macrophage to release IL-10
that in turns reduces inflammation [4]. Other groups have focused on the
use of stimulated MSC to ameliorate their immunosuppressive capabilities
[5]. The main stimulation of MSC has been the use of inflammatory
stimulants like IFNg. Our work focuses on the identification of effective
MSC donors, whether primed with IFNg or naïve, and the development of
in vitro models that will predict how an MSC donor will act in vivo. We
also want to eliminate the use of cells completely and use their secreted
microvesicles as a therapy. The hypothesis is that the in vitro models will
eliminate a noneffective MSC donor and allow us to identify the MSC
donor that will have the greatest effect.
Methods: We developed two in vitro models that are similar to what
happens in vivo with WBC as they circulate in a septic patient. The first test
is the adherence of WBC to a layer of HUVECs in the presence of MSC or
microvesicles. The second is a permeability test to determine MSC ability
to block the permeability of a HUVEC layer.
Results: Our preliminary results have shown that we are able to identify,
using our two in vitro models, which MSC donor would be an effective
MSC for cell therapy.
Conclusion: MSC and their paracrine factors have to the potential to be
an effective therapy for sepsis, but one needs to identify an effective
donor before use in cell therapy.
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Introduction: The Endotoxin Activity Assay (EAA™; Spectral Diagnostics Inc.,
Toronto, Canada) is a useful diagnostic test for sepsis due to Gram-negative
infection and is based on the reaction of neutrophils to endotoxin
complexed with an anti-endotoxin antibody. However, the relations
between values of EAA and microbiological data have not been elucidated.
Our hypothesis is that EAA values correlate to the results of microbiological
cultures and also severity.
Methods: From July 2008 to July 2013, all adult patients with suspected
sepsis admitted to our medico-surgical ICU in whom EAA was measured
were included in this study. Data collected included age, gender, ICU
mortality, white blood cell (WBC) count, C-reactive protein (CRP),
procalcitonin (PCT), EAA levels, SOFA score and results of microbiological
culture. Patients with no microbiological data were excluded. Data were
analyzed by Kruskal-Wallis test, Mann-Whitney U test and multivariate
logistic regression. P < 0.05 was considered significant.
Results: Of 569 patients (353 men and 216 women; mean age 66.0 ±
17.4 years), 283 patients had Gram-negative infection and 286 patients
had no Gram-negative infection. Of 283 patients with Gram-negative
infection, 65 patients had Gram-negative organisms in blood. EAA levels
were significantly different between patients with Gram-negative blood,
in other infectious sites and no Gram-negative infection (0.45 ± 0.21 vs.
0.39 ± 0.17 vs. 0.36 ± 0.15, P = 0.03). The odds ratio (95% confidence
interval (CI)) of EAA levels for Gram-negative infection and Gram-negative
bacteremia were 3.89 (1.44 to 10.4) (P = 0.007) and 3.36 (2.16 to 40.6)
(P = 0.003), respectively. The odds ratio and CI of age and SOFA score for
ICU mortality were 1.03 (1.01 to 1.04) (P = 0.0003) and 1.33 (1.26 to 1.41)
(P < 0.0001), respectively, while gender, WBC, CRP, PCT and EAA levels
had no relations with ICU mortality. SOFA score was significantly higher
in patients with Gram-negative infection than in patients with no Gram-
negative infection (8.0 ± 4.6 vs. 6.7 ± 4.2, P = 0.0003).
Conclusion: EAA levels related to the detections of Gram-negative
organisms in cultures. Thus, a high EAA level may show the existence of
Gram-negative organisms in patients’ sites. EAA levels had relations with
SOFA score but no relations with ICU mortality.
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Introduction: The Endotoxin Activity Assay (EAA™; Spectral Diagnostics Inc.,
Toronto, Canada) is a rapid in vitro diagnostic test of the neutrophil reaction
to endotoxin and reflects the endotoxemia. A higher value of EAA (>0.60)
has been shown to correlate with developing severe sepsis and a high
mortality in other previous studies. We hypothesize that a value of EAA
more than 0.55, not >0.60, may be useful to earlier diagnose sepsis due to
Gram-negative organisms and to assess the severity.
Methods: The present study is a single-center retrospective observational
analysis of adult septic patients in whom EAA was performed from July 2008
to July 2013. Patients were divided into two groups: (1) EAA >0.55 and (2)
EAA < 0.54. Age, sex, days of ICU stay, ICU mortality, body temperature,
WBC, CRP, procalcitonin (PCT), SOFA score, and microbiological data were
compared between two groups. Values are expressed as mean ± SD. Data
were analyzed by chi-square test and Mann-Whitney U test. P < 0.05 was
considered significant. The sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV) and odds ratio were also evaluated.
Results: Five hundred and ninety-four patients (377 men and 217 women;
mean age 65.0 ± 17.5 years) were studied. There were (1) 104 patients with
EAA >0.55 and (2) 490 patients with EAA < 0.54. ICU mortality (39.4 vs. 26.6
%, P = 0.01), PCT (17.2 ± 36.0 vs. 11.8 ± vs. 30.6 ng/ml, P = 0.04), SOFA score
(8.1 ± 4.9 vs. 6.2 ± 4.6, P = 0.04) and positive Gram-negative organisms in
cultures (57.7 vs. 45.5 %, P = 0.02) were significantly higher in group (1) than
group (2). Age, sex, body temperature, WBC and CRP were not significantly
different between two groups. Using detections of Gram-negative
organisms in cultures, the sensitivity, the specificity, the PPV and the NPV
were 22.1, 85.2, 57.7 and 54.6%, respectively. The odds ratio was 1.64.
Conclusion: ICU mortality and severity were higher in patients with EAA
>0.55 than in patients with EAA < 0.54. There is a possibility that an EAA
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value more than 0.55 is a meaningful value for early diagnosis of sepsis
due to Gram-negative infection.
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Introduction: Dengue fever is one of the most important seasonal
epidemics in Asia Case fatality rates vary from 1 to 5% [1]. Mortality from
severe dengue may range from 26% in DHF to as high as 47% in DSS [2,3].
The pathogenesis of shock in dengue fever (DF) is centered on increased
capillary permeability in the critical phase leading to hypovolemia and shock
in severe dengue. There have been multiple studies that compare fluid
regimens in the management of dengue [4,5]. These studies do not assess
the child’s renal function and ability to handle the fluid loads. GFR <60 ml/
minute indicates a significant decrease in the renal functioning and there
are no pediatric studies that examine their association with in-hospital stay
and outcomes in children with severe dengue. With this introduction we
formulated this study protocol to examine that association. The objectives
were to measure the estimated glomerular filtration rate (eGFR) at admission
and fluid balance in the first 36 hours of ICU stay and assess their effect on
disease course and outcomes in severe dengue.
Methods: This was designed as a retrospective descriptive study in a
tertiary-level pediatric ICU in South India. Case records of all children
fulfilling the WHO case definition of severe dengue were included, those
who received intravenous fluid for less than 12 hours were excluded.
Primary parameters measured included fluid balance in the first 36 hours
measured every 12 hours, durations of oxygen requirement, mechanical
ventilation, ICU stay and total hospital stay. Outcomes measured were death
and survival.
Results: Twenty-six children were enrolled, 14 boys and 12 girls. The
median duration of ICU stay was 60 hours, and that of hospital stay 109
hours. eGFR was less than 60 ml/minute in six patients (83.3% expired and
16.7% survived). eGFR, measured by modified Schwartz’s formula, at the
time of admission correlated inversely with requirement of oxygen therapy
and mechanical ventilation (P < 0.05) and fluid balance in the first 36 hours.
Positive fluid balance (FO > 15%) in the first 36 hours was significantly
higher in children who expired (P = 0.011). eGFR <90 ml/minute at
admission had 100% sensitivity and 79% specificity to predict the possible
occurrence of fluid overload >15% (area under curve = 0.882).
Conclusion: Fluid balance in the first 36 hours had a significant positive
correlation with mortality and negative correlation with eGFR. Children with
admission eGFR <90 ml/minute may require restrictive fluid therapy to
improve survival.
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Introduction: This audit evaluates the adherence to the prophylactic
surgical antibiotic policy at Kingston Hospital. With a greater understanding
of the current use of prophylactic surgical antibiotics comes the ability to
improve patient care while minimising the development of antibiotic
resistance. Surgical site infections are a major source of hospital-acquired
infections, causing significant morbidity and mortality. In appropriate cases,
surgical antibiotic prophylaxis is essential in preventing such infections;
however, this comes with increased risks of antibiotic resistance and
antibiotic-associated diarrhoea. Consequently, this institution has extensive
guidelines as to the cases in which antibiotic prophylaxis is required and
what antibiotics should be administered. This audit examines the adherence
to these guidelines. We audited against our local antibiotic prescribing
policy, named the Blue Book guidelines.
Methods: Notes were audited retrospectively for 80 patients undergoing
surgery between 19 August and 18 December 2013. These were audited
against local antibiotic guidelines (Blue Book guidelines) and analysed using
descriptive statistics.
Results: Only 57% of operations were compliant with Blue Book antibiotic
prophylaxis guidelines. For operations where administration of antibiotics
was appropriate, 24% of patients received the incorrect choice, 19% were
given the incorrect dose, 28% were given antibiotics for an inappropriate
time relative to the procedure, and 38% received antibiotics for the incorrect
duration. For operations not requiring prophylaxis, 48% of patients
incorrectly received antibiotics.
Conclusion: Compliance to local guidelines for prophylactic antibiotics is
extremely poor. This not only risks increased morbidity and mortality
from surgical site infections but also risks the development of antibiotic
resistance and Clostridium difficile colitis.
We suggest enhancement of the antibiotic guidelines, and education of
those using them. This will improve the provision of antibiotic prophylaxis in
the Trust, and ultimately improve patient care.
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Introduction: Delay in diagnosis and initiation of antibiotic treatment has
been shown to increase mortality. Biomarkers can play an important role in
diagnosis and prognosis of sepsis. We aimed to evaluate the correlation
between septicemia and high-density lipoprotein (HDL) level in burned
patients.
Methods: A prospective study conducted at Al-Sadr teaching hospital,
Maysan, Iraq, during the period from April to September 2013. Blood
samples were collected from patients every other day to measure the level
of HDL and triglycerides. Other blood samples were collected in blood
culture tubes for culturing to verify septicemia depending on the clinical
evidence.
Table 1(abstract P77) Characteristics of patients
Patient characteristic Average Range
Age (years) 17 1 to 85
TBSA% 33.5% 15 to 95%
Sex of patients Female 61% Male 39%
Burn type Scalds 48% Flame 52%
Most patients were female (61%) with average age 17 years and a wide range
of burned surface area (15 to 95%)
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Results: Seventy-five patients (Table 1) were admitted consecutively into
the burn unit, 35 of them (46%) developed septicemia and 11 of the 35
patients died. All dead patients had HDL value <5 mg/dl 1 or 2 days
before dying since our blood samples were collected every 2 days
(Tables 2 and 3). Other laboratory tests such as WBCs, platelet account,
albumin level, and so forth were made to confirm sepsis (Table 4). A
comparison between the level of lipid profile before and after sepsis
showed a significant drop in HDL level during the onset of sepsis (Table 5).
We also found that patients with HDL value <15 mg/dl were at high risk of
developing sepsis.
Conclusion: There was a strong correlation between HDL level and
septicemia in burn patients. The HDL value is a good biomarker for
sepsis; it decreases below normal level and continues to diminish and
reach an immeasurable level at the advanced stage of septicemia.
Cite abstracts in this supplement using the relevant abstract number,
e.g.: Al-Zaidawi: Presepsis biomarker: high-density lipoprotein. Critical
Care 2014, 18(Suppl 2):P77
Table 2(abstract P77) Lipid profile for all 75 patients at the onset of thermal injury during the first day of admission:
all patients were with a normal range of HDL, triglycerides and cholesterol
Lipid profile Range (mg/dl) Average (mg/dl) Mode (mg/dl) Normal range (mg/dl)
HDL 30 to 56 39 38 39 to 59
Triglycerides 37 to 148 70 58 0 to 149
Cholesterol 46 to 155 78 86 0 to 199
Table 3(abstract P77) Lipid profile at the onset of sepsis showed that HDL level dropped to less than 15 mg/dl with
range (4 to 13 mg/dl): elevation in triglyceride level out of normal range with no significant change in cholesterol
level
Lipid profile Range (mg/dl) Average (mg/dl) Mode (mg/dl) Normal range (mg/dl)
HDL 4 to 13 7.6 4 39 to 59
Triglycerides 133 to 435 214.5 180 0 to 149
Cholesterol 56 to 139 82.8 76 0 to 199
Table 4(abstract P77) Levels of urea, creatinine, albumin, WBC, platelets during onset of sepsis: most patients













Time to get sepsis
(days)
Average 55 11.86 154.9 14 0.51 2.0 7
Mode 45 9.04 121 12 0.37 1.8 10
Minimum 27 2.27 32 9 0.32 1.4 2
Maximum 95 15.03 535 21 0.73 3.1 20
Table 5(abstract P77) Comparison between level of lipid profile before and after sepsis showed the significant
dropping in HDL level during onset of sepsis
HDL Triglycerides Cholesterol P value
Burn onset 39 70 78 < 0.01
Sepsis onset 7.6 214.5 76 < 0.01
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